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Abstract 
 Plants from the genus Daucus L., particularly the species Daucus carota, have been 
widely used over the millennia in folk medicine as treatment for dysentery and kidney 
dysfunction, amongst other ailments, These properties are based upon anecdotal evidence and 
many of them have not been validated using a scientific-based approach, thus justifying further 
investigations on the bioactive properties of these species.  
 The work conducted in this thesis focuses on the taxon D. carota subsp. carota that 
grows spontaneously in Portugal. Essential oil and phenolic-enriched extracts obtained by 
extraction with 70% methanol, 100% methanol and water, from the aerial parts of D. carota 
subsp. carota, were used to access several bioactive properties, namely antibacterial, antifungal, 
antioxidant, anti-inflammatory and cytotoxicity ones. 
 The antibacterial activity of the essential oil and the 70% methanol extract was 
evaluated against several pathogenic bacteria, through determination of the minimal inhibitory 
concentration (MIC) and minimal lethal concentration (MLC). The essential oil had a stronger 
activity when compared to the phenolic extract against Staphylococcus aureus, Listeria 
monocytogenes and Bacillus subtilis (MIC = 0.32 – 0.64 µL/mL versus 5-10 mg/mL). The bacteria 
Escherichia coli and Salmonella typhimurium were resilient against both samples. 
The antifungal properties of the samples were assessed against yeasts (Candida spp. and 
Cryptococcus neoformans), dermatophytes and Aspergillus spp. which are known to cause several 
pathologies both in humans and animals. The MIC and the MLC values showed a significant 
antifungal activity of the essential oil especially against dermatophytes (MIC = 0.32 – 0.64 
µL/mL) and Cryptococcus neoformans (MIC = 0.16 µL/mL).  The 70% methanol extract only 
demonstrated a significant activity against dermatophytes (MIC = 1.25 – 10 µL/mL). The 
inhibition of the germ tube formation and the effect on preformed biofilms of C. albicans was 
also conducted for the essential oil and the results suggest that it might be a promising therapy 
for candidiosis. 
 The antioxidant capacity was also assessed in terms of radical scavenging using the 
ABTS cation radical scavenging assay and the ORAC assay. For the phenolic-enriched extracts 
the total phenolic content was also determined using the Folin-Ciocalteau assay. The total 
phenolic content on all tested samples was very similar between each other indicating that the 
phenolic compounds found in wild carrot have the same solubility in water and methanol. The 
ABTS and ORAC assays demonstrated that the phenolic-enriched extracts have a stronger 
antioxidant activity when compared to the essential oil, which was expected since phenolic 
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compounds are described as having more radical scavenging activity than terpenes and 
terpenoids.  
 Prior to anti-inflammatory assays, NO● scavenging potential of D. carota subsp. carota 
was conducted using SNAP as a NO● donor. The essential oil was unable to scavenge the NO● 
released by SNAP. The anti-inflammatory activity of the essential oil was also performed by 
evaluating the capacity to inhibit the NO release in LSP-stimulated macrophages. The results 
show that the essential oil was able to decrease NO production by 19.04% without 
cytotoxicity to macrophages. 
 In order to further evaluate the potential application of the essential oil in humans, the 
safety profile was determined using different cells (keratinocytes, alveolar epithelial cells, 
macrophages and hepatocytes) mimetizing the main administration routes and the 
metabolization in the organism (liver). The results demonstrated the essential oil in general 
was safe when applied in concentrations lower that 1.25 µL/mL. 
 The present work contributed to a better understanding on the bioactive properties 
of D. carota subsp. carota, and evidenced the industrial potential of this plant.  
 
Keywords: Daucus carota subsp. carota, essential oil, phenolic-enriched extracts, antifungal 
properties, antibacterial properties, antioxidant activity, anti-inflammatory effect, cytotoxicity 
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Resumo 
As plantas do género Daucus L. são desde há séculos usadas na medicina tradicional 
como tratamento para disenteria, disfunção renal, entre outros problemas, particularmente a 
espécie Daucus carota. No entanto estas propriedades são baseadas no conhecimento popular 
e não de estudos científicos, assim justifica-se a necessidade de se realizarem estudos sobre 
as propriedades bioactivas desta espécie, especialmente do taxon D. carota subsp. carota, que 
está amplamente distribuído em Portugal 
Neste trabalho utilizou-se óleo essencial e extratos enriquecidos em compostos 
fenólicos (extração com solução de metanol a 70% (v/v), metanol absoluto ou água), todos 
obtidos a partir das partes aéreas de D. carota subsp. carota. As propriedades bioativas 
estudadas foram as atividade antibacteriana, antifúngica, antioxidante, anti-inflamatória. 
Adicionalmente foi ainda avaliada a citotoxicidade do OE. 
A atividade antibacteriana do óleo essencial e do extrato de metanol 70% foi 
determinada contra várias bactérias patogénicas. O óleo essencial demonstrou uma atividade 
mais intensa que o extrato contra S. aureus, L. monocytogenes e B. subtilis (0.32 – 0.64 µL/mL 
contra 5-10 mg/mL). As bactérias E. coli e S. typhimurium foram resistentes à ação tanto do 
óleo essencial como do extrato. 
As propriedades antifúngicas das amostras foram avaliadas contra leveduras (Candida 
spp. e Cryptococcus neofomans), dermatófitos e Aspergillus spp. que são conhecidos com agentes 
causais de várias patologias tanto em humanos como em animais. A avaliação da concentração 
mínima inibitória (CMI) e da concentração mínima letal (CML) demonstrou que o óleo 
essencial de Daucus carota subsp. carota tem uma atividade significativa especialmente contra 
dermatófitos (0.32 – 0.64 µL/mL) e C. neoformans (0.16 µL/mL). Por sua vez o extrato de 
metanol 70% apenas demonstrou atividade significante contra dermatófitos (1.25 – 10 µL/mL). 
A inibição do tubo germinativo e o efeito em biofilme pré-formado de C. albicans sugere que 
o óleo essencial poderá ser um potencial interesse no tratamento da candidíase. 
 As propriedades antioxidantes das amostras foram avaliadas recorrendo à sua 
capacidade de capturar radicas livres (ABTS) e poder antioxidante através do método ORAC. 
O teor em fenólicos totais foi determinado para os vários extratos fenólicos utilizado o 
método de Folin-Ciocalteau. O teor em fenólicos totais foi muito semelhante entre todas as 
amostras, indicando que os compostos fenólicos presentes na parte aérea de cenoura 
selvagem apresentam igual solubilidade em água e em metanol. Os resultados obtidos para os 
ensaios de ABTS e ORAC demonstram que os extratos fenólicos apresentam uma maior 
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atividade quando comparado com o óleo essencial, o que seria de esperar uma vez que os 
compostos fenólicos estão descritos como sendo mais antioxidantes que os terpenos e 
terpenóides.  
 Antes da determinação das propriedades anti-inflamatórias, a capacidade do óleo 
essencial para capturar NO● foi avaliada usando o SNAP como dador de NO●. O óleo 
essencial não teve qualquer efeito na captura de NO● libertado pela ação do SNAP. A atividade 
anti-inflamatória do óleo essencial foi testada através da inibição da libertação de NO em 
macrófagos estimulados com LPS. Os resultados demonstram que o óleo essencial reduziu a 
produção de NO em 19.04% na concentração de 0.64 µL/mL sem demonstrar citotoxicidade 
para as células. 
 De forma a avaliar a potencial aplicação do óleo essencial em humanos, o perfil de 
segurança foi determinado usando diferente linhas celulares (queratinócitos, células epiteliais 
alveolares, macrófagos e hepatócitos) que mimetizam as principais vias de administração assim 
como o local de metabolização no organismo (fígado). Os resultados demonstram que o óleo 
essencial é seguro em concentrações 
abaixo de 1.25 µL/mL. 
 
O presente estudo contribuiu para um melhor conhecimento sobre as propriedades bioativas 
de D. carota subsp. carota , bem como permitiu evidenciar o potencial industrial desta planta.  
Palavras-chave: Daucus carota subsp. carota, óleo essencial, extratos fenólicos, propriedades 
antifúngicas, propriedades antibacterianas, atividade antioxidante, efeito anti-inflamatório, 
citotoxicidade 
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1. General Introduction 
Medicinal plants play a critical role in primary health care as up to 80% of the 
population, in developing countries, depends on these plants (Newman et al., 2000). About 
25% of prescribed medicines in developed countries derive, directly or indirectly, from plants 
and, if over-the-counter market is accounted, this value may ascend to 50% (Newman et al., 
2000). An assessment carried out by Newman (Newman et al., 2007) demonstrated that 51% 
of the new 983 chemical entities approved as drugs from 1981 to 2006 were natural products, 
natural product derivatives or natural product mimics. The great importance of natural 
products to drug development and drug discovery justify the investigation of natural products 
as novel active agents (Hostettmann et al., 2003). Particularly, plants represent a huge reservoir 
of lead compounds as many species have still not been investigated for their pharmaceutical 
and pharmacological potential (Hostettmann et al., 2003). 
The last years have seen an increasing demand for nature-based products, being the 
impact of the aromatic and medicinal plant market most evident on the health and agricultural 
sectors (Isman, 2006; Khater, 2012; Kong et al., 2003). The number of people that are willing 
to accept such products in detriment of conventional drugs are also increasing. This 
acceptance is justified by a long history of use, better patient tolerance, less side-effects along 
with less environmental concerns (Waqar et al., 2006). This trend hasn’t passed unnoticed by 
several industries that are developing bioactive products that are biodegradable and non-toxic 
to both humans and animals. This development has also encouraged the development of more 
precise and reliable analytical methods that allow the accurate characterization of plant 
metabolites (Phillipson, 2007). In addition, the identification of the most promising compounds 
has been made possible due to the development of screening assays which have been adapted 
to several target organisms, including but not limited to, microorganisms (bacteria, fungi, 
viruses) and invertebrates (insects, crustaceous, molluscs) (Hostettmann et al., 2003).  
Recently, investigation on aromatic plants, particularly essential oils, has attracted 
several researchers (Bakkali et al., 2008). These compounds have been used by local 
communities as they have several medicinal properties, namely bactericidal, virucidal, 
fungicidal, anti-parasitic and insecticidal (Bakkali et al., 2008). Nevertheless, these uses are 
mainly based on old beliefs and faith, lacking a scientific approach to support their efficacy. In 
vitro screening programs, based on ethnobotanical approaches, have shown to be a very 
efficient methodology for the validation of traditional uses and the search of new active 
compounds (Alviano et al., 2009; Zuzarte, 2012). Currently, many aromatic plants and their 
I. General Introduction and Objectives 
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essential oils are highly valued in the pharmaceutical, agronomic, food, sanitary, cosmetic and 
perfume industries (Bakkali et al., 2008; Zuzarte, 2012). 
The Apiaceae (Umbelliferae) family comprises several aromatic plants with economic 
interest. Particularly, the genus Daucus L. includes several plants whose essential oils are 
greatly prized in the food and fragrance industries. Also, potential medicinal properties can be 
envisaged due to its use in traditional medicine to treat several ailments  (Guinoiseau et al., 
2010). This genus includes several species that are split into 5 sections: sect. Daucus, sect. 
Platyspermum, sect. Anisactis, sect. Chrysodaucus and sect. Meoides. Sáenz Laín in 1981 described 
20 species of Daucus, later this number ascended to 25 in a study published by Rubatzky and 
colleagues (Rubatzky et al., 1999). Geographically, the plants from this genus can be found from 
the Mediterranean and North African regions across North America and Australia (Sáenz Laín, 
1981). The only cultivated species of carrot is the subspecies Daucus carota subsp. sativus that 
resulted from a domestication process of populations of wild carrots in Central Asia (Arbizu 
et al., 2014; Vivek et al., 1998) while the subspecies Daucus carota L. subsp. carota L. is the best-
known wild species  of this genus (Arbizu et al., 2014). 
Wild carrots have been widely used in folk medicine as a therapeutic agents against 
several ailments (Guinoiseau et al., 2010). Namely, seeds from Daucus carota are described as 
aromatic, carminative, diuretic, aphrodisiac and stimulant (Chizzola, 2010; Guinoiseau et al., 
2010). They are used in the treatment of dropsy, chronic dysentery, stomach disorders, 
hepatic injury, kidney dysfunction and worm troubles. Some authors have also described that 
wild carrot seeds show anti-fertility and anti-steroidogenic effects and due to this are 
consumed by some Indian tribes as birth control. Their effect on swelling and tumours is also 
described (Guinoiseau et al., 2010). 
In addition to the medicinal effects of seeds, the roots from Daucus carota are also 
described as having beneficial effects on several disorders, primarily due to their diuretic and 
ophthalmic properties (Guinoiseau et al., 2010). Moreover, poultices containing roots of wild 
carrots are used against mammary and uterine carcinoma and skin cancer; scraped roots are 
known to be stimulant for indolent ulcers and grated or mashed raw roots can be safely used 
against threadworms, especially on children (Guinoiseau et al., 2010).  
Besides using plant parts per se, traditional medicine also employs volatile (essential 
oils) and non volatile extracts from Daucus carota (Guinoiseau et al., 2010). These are used for 
the treatment of renal and hepatic insufficiency as well as for skin disorders (Guinoiseau et al., 
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2010; Maxia et al., 2009). Particularly, ethanolic extracts of defatted seeds are found to improve 
cognitive functions in mice (Chizzola, 2010).  
In turn, Daucus carota essential oils, demonstrate a wide range of biological properties, 
such as antibacterial, fungicidal, hepatocellular regenerator, general tonic and stimulant. It is 
also used to decrease cholesterol levels and as a cicatrising agent (Guinoiseau et al., 2010).  
2. Objectives 
 
Considering that Daucus carota is extensively used in traditional medicine as a 
therapeutic agent and that several studies lack subspecies identification, which is important 
considering the high intraspecific polymorphism in D. carota, the work conducted in this thesis 
aims to contribute to the clarification of the bioactive properties of both the essential oil and 
the phenolic-enriched extracts of wild carrot, D. carota subsp. carota, as follows: 
 Evaluation of antioxidant properties using 2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid (ABTS˙+) scavenging, oxygen radical antioxidant capacity (ORAC) 
and nitric oxide scavenging assays. 
 Evaluation of antimicrobial properties against several pathogenic microorganisms, 
namely yeasts (Candida albicans, C. krusei, C. tropicalis, C. guillermondi, C. parapsilosis 
and Cryptococcus neoformans), dermatophyte strains (Trichophyton mentagrophytes, 
T. mentagrophytes var. interdigitale, T. verrucosum, T. rubrum,  Microsporum canis, M. 
gypseum, Epidermophyton floccosum), Aspergillus strains (A. niger, A. flavus, A. 
fumigatus) as well as several bacterial strains (Listeria monocytogenes, Salmonella 
typhimurium, Escherichia coli, Staphylococcus aureus, and Bacillus subtilis). In addition, 
the ability of the most active extract to inhibit the germ tube formation of C. 
albicans and disrupt its preformed biofilms was assessed. 
 Assessment of the anti-inflammatory properties of the most active extract on 
lipopolysaccharide-stimulated RAW 264.7 (macrophages) through quantification 
of the inhibition of nitric oxide production (Griess assay). 
 Evaluation of the safety profile of the most active extract against several cell lines 
(macrophages, keratinocytes, alveolar epithelial cells and hepatocytes). This is a 
crucial step for a further pharmaceutical or cosmetic application. 
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1. Introduction 
The term “essential oil” was thought to be first used by Paracelsus von Hohenhein that 
named the active compound of a drug as “Quinta Essentia” in the 16th century (Perricone et 
al., 2015; Russo et al., 2015; Vergis et al., 2013). Turpentine oil was mentioned as long as the 
Greek and Roman cultures. Also, the distillation process was described by Egyptian, Indian and 
Persian cultures more than 2000 years ago with the first authenticated writing about essential 
oil distillation being accredited to Villanova (1235-1311), a Catalan physician (Vergis et al., 
2013). More recently, the European Pharmacopeia 7.0 (Council of Europe, 2010) defined 
essential oil as a “Odorous product, usually of complex composition, obtained from a 
botanically defined plant raw material, by steam distillation, dry distillation, or a suitable 
mechanical method without heating. Essential oils are usually separated from the aqueous 
phase by a physical process that does not significantly affect their composition”. This mixture 
of compounds can also be called of volatile or ethereal oil (Russo et al., 2015; Vergis et al., 
2013). This definition excludes other aromatic/volatile extracts obtained using other extractive 
techniques like, solvent, supercritical fluid or microwave assisted extraction. (Council of 
Europe, 2010; ISO TC 54 - ISO 9235, 1997; Zuzarte et al., 2015). In addition essential oils are 
different in terms of both chemical and physical properties when compared to fixed or fatty 
oils (Zuzarte et al., 2015)(Zuzarte and Salgueiro, 2015). Hydrodistillation is the most 
commonly used methodology to obtain essential oils in a laboratorial scale. The European 
Pharmacopeia recommends the usage of a Clevenger apparatus for the hydrodistillation of 
essential oils as it allows the recycling of condensates leading to a greater yield (Asbahani et 
al., 2015). 
Essential oils can be obtained from different parts of aromatic plants and are a result 
of their secondary metabolism (Asbahani et al., 2015; Bayala et al., 2014; Russo et al., 2015; Sá 
et al., 2014; Tongnuanchan et al., 2014). They are highly volatile and hydrophobic liquids, also 
lipophilic, soluble in organic solvents and immiscible in water (Asbahani et al., 2015; Russo et 
al., 2015).  
Essential oils are biosynthesised in secretory structures present in several plant parts 
such as flowers (e.g. Jasminum, Rosa, and Lavandula species), flowering aerial parts (e.g. Thymus, 
Lavandula, Daucus species), buds (e.g. Syzygium spp.), leaves (e.g. Eucalyptus spp.), fruits (e.g. 
Pimpinella anisum), twigs (e.g. Pistacia lentiscus L.), bark (e.g. Cinnamomum spp.), zest/epicarp 
(e.g. Citrus spp.), seeds (e.g. Elettaria and Amomum species), wood (e.g. Santalum spp.), rhizome 
and roots (e.g. Zingiber spp.) (Asbahani et al., 2015; Bayala et al., 2014; Mann et al., 2014; 
Perricone et al., 2015; Tongnuanchan et al., 2014). Yields of essential oils varies greatly with 
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species but also with the plant part used for oil extraction. However, the value remains usually 
low (about 1%) making essential oils a prized and rare substance (Asbahani et al., 2015). 
Aromatic species account for 10% of all known plants (Asbahani et al., 2015) and mainly belong 
to the following botanic families: Lamiaceae, Apiaceae, Lauraceae, Asteraceae, Rutaceae, 
Myrtaceae, Poaceae, Cupressaceae and Piperaceae (Asbahani et al., 2015; Zuzarte, 2012). 
Although they can be found worldwide most aromatic plants grow on temperate and warm 
climates, such as Mediterranean or tropical countries (Bayala et al., 2014; Perricone et al., 
2015). Most of the aromatic species are included in the GRAS (Generally Regarded As Safe) 
list approved by the FDA (Food and Drug Administration) and EPA (Environmental Protection 
Agency) (Zuzarte, 2012).  
Essential oils are synthesised and stored in specialized histological structures known as 
secretory structures that can be divided into two types: external or internal, depending on 
the location in the plant. External secretory structures can be found on the surface of plant 
organs whereas internal secretory structures are present inside the plant tissues. (Asbahani et 
al., 2015; Svoboda et al., 2000). The external structures include osmophores, glandular 
trichomes andepidermal cells while the internal structures are secretory cells (often 
idioblasts), secretory cavities and secretory ducts.  
Regarding the external secretory structures, osmophores are secretory cells that are found 
in flower tissue and are structurally different than the envolving cells. Glandular trichomes 
(modified epidermal hairs) are found covering leaves, stems and some flower parts (e.g .calyx). 
Considering the most used terminology, these structures are divided into peltate and capitate 
trichomes and are characteristic of the Lamiaceae family (Svoboda et al., 2000; Zuzarte, 2012). 
Epidermal cells are conical epidermal cells that secrete volatile compounds and are generally 
found on flowers (e.g. Rosa spp.) and the yields in essential oil is normally very low.  
Regarding internal structures: secretory ducts are canals that sometimes encompass the entire 
length of the plant and are delimited by secreting cells. They are found in all the members of 
the Apiaceae family and in some members of Coniferae and Pinaceae (Svoboda et al., 2000). 
Secretory cells are specialised cells that produce essential oil and accumulate it in the vacuoles. 
They can be found on cinnamon and laurel, amongst others. The secretory cavitities are 
common on plants from the genera Citrus and Eucalyptus (Romane et al., 2005; Svoboda et al., 
2000). These cavities are intercellular spaces often spherical in form and which are filled with 
essential oil that is secreted by the adjacent cells (Asbahani et al., 2015; Svoboda et al., 2000). 
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Essential oils are a complex mixture of volatile compounds with low molecular weight and 
highly variable concentrations (Asbahani et al., 2015; Perricone et al., 2015; Russo et al., 2015). 
Based on the chemical structure, the major compounds found in essential oils are generally 
terpenes either hydrocarbons and/or oxygenated compounds (Tongnuanchan et al., 2014). The 
former are made of several isoprene units (C5 units). The most common terpenes found on 
essential oils are monoterpenes (C10, e.g. limonene, α-phellandrene) and sesquiterpenes (C15, 
e.g. humulene, germacrene). Diterpenes (C20) can be present in essential oils, but usually in 
very low concentrations (Tongnuanchan et al., 2014). Oxygenated compounds are oxygen-
containing compounds that are designated as “terpenoids” when are terpene-derived although 
other families can be present (Asbahani et al., 2015; Bayala et al., 2014; Russo et al., 2015; 
Tongnuanchan et al., 2014). The main families of oxygen-containing compounds that can be 
found in essential oils are: phenols (e.g. thymol, carvacrol), mono- (e.g. borneol, α-terpineol) 
and sesquiterpene (e.g. elemol, α-santalol) alcohols, aldehydes (e.g. citral, citronellal), ketones 
(e.g. menthone, camphor), esters (e.g. geranyl acetate, linalyl acetate), oxides (e.g. 1,8-cineole, 
linalool oxide), and lactones (e.g. psoralen, bergaptene) (Tongnuanchan et al., 2014). In addition 
to the aforementioned compounds, some essential oils contain a special class of compounds 
known as phenylpropanoids (e.g. eugenol, cinnamaldehyde). These compounds are primarily 
found in Sassafras spp., Chrysopogon zizanioides, Syzygium aromaticum, Cinnamomum verum and 
other Cinnamomum species (Asbahani et al., 2015; Vergis et al., 2013).  
Terpenes are formed by coupling of isoprene units (Wedler et al., 2015). They are 
often polycyclic and result from rearrangements of acyclic precursors by terpene 
synthase/cyclase enzymes (Wedler et al., 2015). There are two pathways that are responsible 
for the biosynthesis of terpenes, the mevalonate (MVA) and 2-C-methyl-D-erythritol 4-
phosphate/1-deoxy-D-xylulose 5-phosphate (MEP/DXP) pathways (Figure 1) (Ikram et al., 
2015; Wedler et al., 2015). Both pathways lead to the formation of isopentenyl pyrophosphate, 
which is the building block of these compounds (Ikram et al., 2015). The MEP/DXP pathway, 
also known as non-mevalonate pathway, which occurs in plastids (e.g. chloroplasts) is mainly 
responsible for the production of mono- and sesquiterpenes as well as diterpenes (Zuzarte 
and Salgueiro, 2015). This pathway starts with the condensation of glyceraldehyde-3-
phosphate with pyruvate which, after several enzymatic conversions, yield isopentenyl 
diphosphate (IDP) and dimethylallyl diphosphate (DMADP) (Ikram et al., 2015; Song et al., 
2014; Wedler et al., 2015). Conversely, the MVA pathway takes place in the cytosol and yields 
mainly sesquiterpenes. This synthetic pathways produces IDP by converting Acetyl-CoA into 
mevalonate which is further metabolized into mevalonate-diphosphate which is processed by 
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mevalonate diphosphate decarboxylase yielding IDP (Ikram et al., 2015; Song et al., 2014; 
Wedler et al., 2015). IDP and DMADP can be interconverted into each other. DMADP is 
condensed with IDP to yield geranyl diphosphate (GDP). The latter can be converted in 
farnesyl diphosphate (FDP) at the expense of another IDP molecule. To FDP is added another 
IDP molecule yielding geranylgeranyl diphosphate (GGDP). GGDP can be formed directly from 
DMADP using 3 IPP molecules by the action of a multifunctional geranylgeranyl diphosphate 
synthase (Ikram et al., 2015; Song et al., 2014; Wedler et al., 2015). GDP, FDP and GGDP are 
then metabolized by terpene synthases yielding mono-, sesqui- and diterpenes, respectively 
(Ajikumar et al., 2008).   
 
 
 
Figure 1 - Terpenoid biosynthesis in plants. Solid 
and dashed arrow represent single and multiple 
enzymatic steps, respectively. DMADP - dimethylallyl 
diphosphate; FDP - farnesyl diphosphate; GDP - 
geranyl diphosphate; GlyAld-3P - glyceraldehyde -3-
phosphate; HMG-CoA – hydroxymethylglutaryl-CoA; 
IDP – isopentenyl diphosphate; MVA – mevalonic acid; 
MEP – methyl erythritol phosphate; CYTP450 – 
cytochrome P450 hydroxylase; FPS – FDP synthase; 
GPS – GDP synthase; HGMR – HMG-CoA reductase; 
MTS – monoterpene synthase; STS – sesquiterpene 
synthase. (In: Bouwmeester, 2006) 
 
Phenylpropanoids, which are common compounds in some plant species namely cinnamon and 
clove are derived from the phenylpropanoids pathway. The shikimate pathway is the entry to 
this biosynthetic pathway (Vogt, 2010). After enzymatic activity shikimate originates 
phenylalanine, which further undergoes modifications during the general phenylpropanoid 
pathway. These modifications lead to the formation of p-coumaroyl CoA after the action of 
phenylalanine ammonia lyase, cinnamate 4-hydroxylase and p-coumaroyl CoA ligase. p-
coumaroyl CoA is then submitted to several enzymatic and structural modifications to form 
several secondary metabolites, e.g. cinnamaldehyde and eugenol (Liu et al., 2015; Tohge et al., 
2013; Vogt, 2010). 
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I. Introduction  
Phenolic-enriched extracts are solutions that are rich in polyphenols, i.e. a group of 
secondary metabolism-derived compounds. Although they do not participate in growth and 
energy metabolism, polyphenols are also crucial to plant survival, as they are produced as a 
response to environmental, ecological or physiological stresses, e.g. UV radiation and 
wounding (Garcia-Salas et al., 2010; Harnly et al., 2007; Khoddami et al., 2013). In addition, 
phenolic compounds play a role in the production of root nodules and in the plant immune 
system’s response (Harnly et al., 2007).  
Phenolic compounds are derived from widespread precursors (AcetylCoA, shikimate and 
amino acids) (Harnly et al., 2007). Structurally speaking, these compounds have at least one 
aromatic ring and one or more hydroxyl moieties that are rearranged in different forms, giving 
origin to the main phenolic compounds family (Garcia-Salas et al., 2010; Harnly et al., 2007; 
Khoddami et al., 2013). These families are simple phenols and benzoquinones (C6), phenolic 
acids (C6-C1), acetophenones, phenylacetic acid (C6-C2), cinnamic acids, phenylpropene, 
coumarins, chromones (C6-C3), naphthoquinones (C6-C4), xanthones (C6-C1-C6), stilbenes, 
anthraquinones (C6-C2-C6), flavonoids (C6-C3-C6), lignans, neolignans ((C6-C2)2), tannins ((C6-
C1)n) and lignins ((C6-C3)n) (Garcia-Salas et al., 2010; Harnly et al., 2007).  
Although there are several families, the most predominant in plants are the phenolic 
acids/cinnamic acids and flavonoids (general structures in Figure 2), with mean abundance of 
30% and 60%, respectively (Garcia-Salas et al., 2010). The former can be found as aglycones 
(free form), esters, glycosides and/or bound complexes. These structural differences make the 
phenolic and cinnamic acids more suitable for certain extraction methods and vary their 
susceptibility to degradation (Garcia-Salas et al., 2010). In turn, the basic structure of flavonoids 
comprises two aromatic rings linked by three carbons, which normally form an oxygenated 
heterocycle and are derived from the aromatic amino acids, phenylalanine and tyrosine 
(Garcia-Salas et al., 2010; Khoddami et al., 2013). Like phenolic and cinammic acids, flavonoids 
can be found as aglycones, however they are normally found as glycosidic derivatives which 
can be responsible for the colours (blue, scarlet and orange) of leaves, flowers and fruits 
(Garcia-Salas et al., 2010). Flavonoids can still be divided into 13 structurally different classes: 
chalcones, dihydrochalcones, auron, flavones, flavonols, dihydroflavonols, flavanones, flavanols 
(catechins), flavandioles (leucoanthocyanidins), anthocyanidins (glycosides: anthocyanins), 
isoflavanones, condensed tannins (proanthocyanidins) and flavonoids (Garcia-Salas et al., 2010). 
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These structural differences depend on the scale and pattern of hydroxylation, prenylation, 
alkalinisation and glycosylation reactions that flavonoids undergo (Khoddami et al., 2013).  
OH
O OH
OH
O OH
OA                                       B                                       C
 
Figure 2 - General structure of main phenolic compounds found in plants: A - hydroxybenzoic acid, B - 
hydoxycinnamic acid, C - flavonoid 
 
It is thought that there are more than 8000 phenolic compounds in the plant kingdom which 
are divided into the groups aforementioned (Garcia-Salas et al., 2010). Of those, more than 
450 are flavonols, 400 flavones, 350 flavanones, 300 isoflavones, 19 anthocyanidins and 350 
chalcones. The glycosidic derivatives of flavonoids are accounted as more than 5000 different 
compounds (Harnly et al., 2007). 
The extraction of phenolic compounds is not so straightforward when compared to essential 
oils because they can be found in a panoply of conditions which affect their solubility in the 
solvent used during the extraction. Thus, no extraction process is able to extract all the 
phenolic compounds in the plant matrix (Garcia-Salas et al., 2010).  
The extraction of phenolic compounds from solid matrixes is normally achieved by using 
Soxhlet, heated reflux extraction or maceration (Garcia-Salas et al., 2010; Khoddami et al., 
2013). The two first methods are commonly performed at high temperatures (around 90ºC) 
during several hours while maceration can be as long as a few days. Nevertheless all these 
extraction methods are still widely used as they are quite simple, require cheap apparatus and 
have adequate phenolic extraction rates (Khoddami et al., 2013).  
In turn, the extraction of phenolic constituents from liquid samples is normally achieved by 
the use of liquid-liquid extraction. However, this method requires expensive and dangerous 
solvents (e.g. propanol, dichlorometane and other organic solvents) (Net et al., 2015; Saraji et 
al., 2014) and a long extraction time which can trigger the degradation of compounds, mainly 
because of light, air and temperature. In order to avoid these effects on the phenolic 
compounds, new extraction methodologies have been proposed, such as solid-phase 
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extraction, pressurized liquid extraction, microwave-assisted extraction, ultrasound-assisted 
extraction and supercritical fluid extraction. In addition microextraction techniques have also 
been developed, such as solid-phase microextraction, single-drop microextraction, dispersive 
liquid-phase microextraction, amongst several others (Garcia-Salas et al., 2010; Leong et al., 
2014; Net et al., 2015; Saraji et al., 2014). 
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1. Taxonomy 
The genus Daucus was first described by Carl Linnaeus in his works regarding the 
taxonomy of the plant kingdom, the Species Plantarum, exhibentes plantas rite cognitas, ad 
genera relatas, cum differentiis specificis, nominibus trivialibus, synonymis selectis, locis natalibus, 
secundum systema sexuale digestas, first published in 1753 (Linnaeus, [s.d.]); the Genera 
plantarum: eorumque characteres naturales secundum numerum, figuram, situm, et 
proportionem omnium fructificationis partium, first published in 1737 (Linnaeus, [s.d.]) and 
Systema Naturae, first published in 1735 (Linnaeus, [s.d.]).  
The genus Daucus belongs to the Umbelliferae (Apiaceae) family and, although 
widely distributed and cultivated in temperate regions of the world, its dispersion is mainly 
centred in the Mediterranean region, more specifically in North Africa (Sáenz Laín, 1981). 
Nevertheless, some species from Australia and from North America have also been 
described (Sáenz Laín, 1981).  
Daucus L., Sp. Pl. 242 (1753) 
Annual, biennial or perennial herb. Roots from taproot to napiform. Erect stem, 
ascendant or decumbent, glabrous, pubescent, velutinus, scabrid, hispid, more or less 
branched from the base or in the upper half. Basal leaves (1)2-4(5) pinnatisect, superior 
ones smaller. Composite umbels, occasionally with a sterile central flower, it can get to 
130 rays, even or uneven, frequently strongly arched in the fructification. Numerous 
bracts, pinnatisect, sometime pinnatifid, rarely undivided, occasionally similar to leaves, 
with scabrous in the base. Bracteoles present, undivided, bifid or trifid. Calyx 
inconspicuous serrated, triangular. White petals, most of the time purple toned, or yellow, 
curved apex, external side of exterior flowers are frequently larger than the internal. 
Ringed stylopodium, discoidal or conical in the anthesis – conical or cylindrical in the 
fructification; styles more or less straight, parallel or divergent. Ellipsoidal fruits, oblong, 
ovoid or subspherical, somewhat compressed dorsally, rarely not compressed; mericarps 
with 5 primary ridges little evident and hairy, and 4 secondary ridges with a spines generally 
glochidial. Seeds with flat or slightly concave endosperm on the commissural face (Salvá, 
2003). 
The genus Daucus includes 5 sections, each one with their unique characteristics 
(Sáenz Laín, 1981; Salvá, 2003). The sect. Daucus, is the largest of the five and encompasses 
the following species: D. carota L., D. gracilis Steinh., D. guttatus Sm., D. involucratus Sm., D. 
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jordanicus Post, D. saharensis Murb., D. syrticus Murb., D. capillifolius Gilli, D. crinitus Desf., 
D. tenuisectus Coss., D. montevidensis Link ex Sprengel and D. pusillus Michx. Amongst them, 
the species found in the Iberian Peninsula in accordance to Flora Iberica X are D. carota, 
D. arcanus, D. aureus, D. crinitus, D. durieua, D. muricatus and D. setifolius (Salvá, 2003). Of 
those spontaneous plants, the work conducted here will focus on Daucus carota, more 
specifically on the wild carrot subspecies, D. carota subsp. carota. 
1.1. Daucus carota L.  
Daucus carota L. is also known as wild carrot, “bird’s 
nest”, “devil’s plague” and “Queen Anne’s lace” (Guinoiseau et 
al., 2010; Rokbeni et al., 2013) and in Portuguese as salsa-burra, 
cenoura-brava or erva-coentrinha, amongst other common 
names (Salvá, 2003), This species has its endemic centre in the 
Mediterranean region however it can also be found growing wild 
on temperate regions of Europe, North America, Siberia, 
Northern and Southern India, North Africa and Southeast Asia 
(Guinoiseau et al., 2010; Rokbeni et al., 2013). The plant is a tall 
and robust herb with spiny fruits that can be found on dried-out 
fields and meadows (Chizzola, 2010; Guinoiseau et al., 2010). 
The distribution of wild carrot in Portugal is represented in 
Figure 3. 
 
D. carota L., Sp. Pl. 242 (1753) 
Annual or biennal plant, frequently monocarpic, (3)10-170(220) cm, erect, 
ascendant or occasionally decumbent, branched or not since its base. Glabrous, scabrous, 
hispid or densely velutinus stem – reflexed or patent hair. Basal leaves 1-4(5) pinnatisects, 
with last order division, obovate, oblong or lanceolate to linear, mucronate, frequently 
peciolated and limbus from hirt to hispid, rarely glabrouscent or glabours; the upper 1-3 
pinnatisect, similar to the basal, smaller in size, rarely absent or very scarse, often with 
last order division from linear to lanceolated, glabrous or glabrouscent, sometimes with 
indumentum similar to basal leaves. Umbels greatly pedunculated, rarely subsessile, 1.5-23 
cm in diameter, slightly concave, flat, convex, hemispheric or globular, from strongly 
contracted to not contracted in the fructification, with 9-130 rays, the external of 8-110 
Figure 3 - Distribution 
map of Daucus carota L. 
subsp. carota in Portugal 
(Almeida et al., 2015) 
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mm, uneven, from hirsute to scabrous, rarely glabrous or subglabrous. Bracts 5-14, with 
length equal or less than those of rays, apprised or reflexed, sometimes patent in the 
anthesis and in the fructification, pinnatisect, sometimes pinnatifid, rarely undivised, with 
filiform lobes, linear or lanceolated, occasionally ovoid, glabrous or glabrouscent, 
sometimes hirsute, with scarious and ciliated margins –rarely glabrous. Bracteoles 5-10, 
with length equal to that of the flowers, undivided – from linear to amply lanceolated – or 
occasionally 2-3-fid, glabrous, subglabrous, pubscent, scabrous or hirt, with scarious and 
ciliated margins – sometimes glabrous. Central sterile and purple flower present or absent. 
Sepals dented 0.1-0.2 mm, triangular, whitish or pale green. Petals 0.5-3.5 mm, external of 
exterior flowers larger than the internal – sometimes scarcely-, from cordate to ovoid, 
emarginated, frequently with very uneven lobules, acuminate, curved, white, rarely 
yellowish white, occasionally purple-, white- or dry yellow-toned. Anther yellow, 
occasionally white or purple. Ringed stylopodium – more or less conical in the 
fructification; styles 0.2-0.5 mm – 0.5-1.3 mm, parallel or scarcely divergent in the 
fructification. Fruits 1.5-4 mm, ovoid, oblong, elliptical or suborbicular, brown or purplish; 
mericarps with primary ridges with (1)2-3 rows of simple hair, white; the secondary with 
spine larger or smaller than the width of the mericarps, thin or thick, dilated or not, and 
confluent in a crest or not in the base, white, occasionally purple, with starred glochids or 
glochids 1-2(3) bristled. 
 In the Volume X of the Flora Iberica (Salvá, 2003), eleven subspecies of D. carota 
were considered and described, being five of them found in Portugal Nevertheless, the 
following sections will only consider subsp. carota since it is the species studied in this 
work. 
Key to the subspecies carota: (Adapted from Flora Iberica X (Salvá, 2003)) 
1.  Bracts with last order sublinear division or filiform, umbels, in the fructification, 
with rays markedly arched-convergent (strongly contracted), rarely with ray little 
arched-convergent; mericarp secondary ridges with thin spines, scarcely dilated 
and only confluent in one crest at the base     
       2. 
Bracts with last order ovoid divisions, lanceolate, or linear-lanceolate (wide), 
rarely sublinear; umbels, in the fructification, with rays little arched-convergent or 
more or less straight (little contracted); secondary ridges in the mericarp with 
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thick spines, dilated and confluent in a crest at the base or thin, scarcely dilated 
and only confluent in a crest at a base                                 2. 
2. Root non napiform, fibrous, whitish, wild plants              3. 
3. Plant (4)25-110 cm; basal leaves 1-3(4) pinnatisect, umbel with (1.5)3-7(11)cm in 
diameter in the anthesis; fruits 1.8-3.2 mm             subsp. 
carota 
 
Wild carrot is a variable biennial plant that reproduces solely by seeds (Figure 4). The 
flowering periods ranges from June to August while the seed maturation phase occurs 
from August to September. During the first year of growth the formation of a rosette of 
lobed, deeply dissected leaves can be observed, conversely the leaves on the flowering 
stems, which are formed during the second year of growth, are oblong and alternate. 
(Guinoiseau et al., 2010). The flowering umbel of D. carota subsp. carota is represented in 
Figure 5 where it can be seen the characeteristic dark flower in the middle. 
 
 
 
 
 
 
 
 
 
2. Nutritional and phytochemical components of carrot root 
Carrot roots have a moisture/water content that varies from 86 to 90% 
(Guinoiseau et al., 2010; Sharma et al., 2012). This vegetable is a good source of minerals, 
protein and carbohydrates as well as vitamins and other phytonutrients (Sharma et al., 
2012). The content on carbohydrates ranges from 5 to 10%, with reducing sugars summing 
up 1.67 to 3.35% and non-reducing 1.02 to 1.18% (Sharma et al., 2012). The most common 
Figure 4 - Daucus carota subsp. carota 
umbel, in middle it can be seen the central 
darkish flower. Found at http://www.flora-
on.pt/#/hC8go 
Figure 5 - Seeds from Daucus carota subsp. 
carota. Found at http://www.flora-on.pt/#/haH2l 
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sugars on carrots are sucrose, fructose, glucose and xylose (Guinoiseau et al., 2010; 
Sharma et al., 2012). Carrots are also rich in dietary fibres, with mean values of insoluble 
fibres ranging from 1.2 to 2.4%, from which 71.7%, 13% and 15.2% consists of cellulose, 
hemicellulose and lignin, respectively. In addition, carrots are also a source of soluble 
fibres, such as pectins (Sharma et al., 2012) and a primary source of pro-vitamin A yielding 
14-17% of total vitamin A consumption (Alasalvar et al., 2001; Nicolle et al., 2004). 
Carotenoid concentration in carrots varies from 5.33 to 54.8 mg/100g (Sharma et al., 
2012). Six types of carotenoids have been described, α-, β-, γ- and ζ-carotene, lycopene 
and β-zeacarotene (Alasalvar et al., 2001; Nicolle et al., 2004), being α- and β-carotene 
(structure shown in figure 6) the most predominant and most biologically relevant, which 
activity resembles 50% and 100% of that of pro-vitamin A, respectively (Alasalvar et al., 
2001; Sharma et al., 2012).  
CH3 CH3
CH3
CH3 CH3
CH3 CH3
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Figure 6 - β-carotene structure 
 
Among phenolic compounds, carrot roots are mostly rich in anthocyanins. The 
content of these phenolic compounds  is largely variable showing only traces on pink 
carrots and 16-71 mg/100g in orange carrots, 179 mg/100g in black carrots and 100-243 
mg/100g in purple carrots (Leja et al., 2013; Sharma et al., 2012). The most common 
anthocyanins found in carrots are cyanidin-3-(2-xylosylgalactoside) (Figure 7A1), cyanidin-
3-xylosylglucosylgalactoside (Figure 7A2) and cyanidin-3-ferulylxyloglucosylgalactoside 
(Figure 7A3) (Sharma et al., 2012). Moreover, minor antocyanins have also been described, 
namely peonidin (Figure 7A4) and pelargonidin (Figure 7A5) glycosides (Kammerer et al., 
2003, 2004) 
Regarding other phenolic compounds in carrot roots, it has been shown that they 
are mostly rich in hydroxycinnamic acids esterified with quinic acid (Kammerer et al., 
2004) and are free of flavonols, although apigenin (Figure 7B1), kaempferol (Figure 7B2) 
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and luteolin (Figure 7B3) glycosides derivatives can also be found (Carlos, 2014). 
Chlorogenic acid, an caffeyolquinic acid isomer, accounts from 42.2% to 61.8% of total 
phenolic compounds in carrots (Carlos, 2014). Specifically, orange, purple, yellow and 
white carrots collected from United Kingdom are rich in caffeyolquinic acid (Figure 7C1) 
isomers, p-coumaroylquinic acid (Figure 7C2) isomers and feruloylquinic acid (Figure 7C3) 
isomers as well as the aglycone of caffeic acid (Alasalvar et al., 2001). These phenolic acids 
have also been described in black carrot (Daucus carota subsp. sativus var. atrorubens Alef.).  
In addition, carrots are also a source of polyacetylenes, namely falcarinol and falcarindiol 
(Carlos, 2014). Moreover, coumarins and oxygenated acyclic diacethylene derivatives have 
been isolated from Daucus carota subps. carota roots (Guinoiseau et al., 2010). 
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Figure 7 - Major phenolic compounds found in carrot: A - anthocyanins, B - quinic acid 
derivatives, C - flavones 
 
3. Daucus carota essential oil 
Daucus carota essential oil can be obtained from different plant parts, such as seeds, 
aerial parts or roots (Guinoiseau et al., 2010). It is however known that the essential oil 
yield decreases when moving from seeds to aerial parts (umbels and leaves) and to roots 
(Guinoiseau et al., 2010). Previous studies have described that seed essential oil yield is 
C1 – R1: caffeic acid 
C2 – R1: p-coumaric acid 
C3 – R1: ferulic acid 
A1 – R1: 2-xylosylgalactoside, R2: OH 
A2 – R1: xylosylglucosylgalactoside, R2: OH 
A3 – R1: ferulylxyloglucosylgalactoside, R2: OH 
A4 – R1: H, R2: OCH3 
A5 – R1: H, R2: OH 
 
B1 – R1=R2: H 
B2 – R1: OH, R2: H 
B3 – R1: H, R2: OH 
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highly variable with values ranging from 0.05% to 7.15% while oil isolated from roots of 
Daucus species have a very low yield (0.004%) (Guinoiseau et al., 2010). 
Moreover, the chemicalcomposition of carrot seed essential oil is greatly variable. The 
most common families of secondary metabolites found are terpenes, both mono and 
sesquiterpenes, as well as phenylpropanoids (Guinoiseau et al., 2010). Five main 
compositions can be described. Three are characterized by the existence of a terpenic 
main component, namely carotol, geranyl acetate or sabinene (Figure 8), while the fourth 
family is described as having these three components in an equal ratio (Guinoiseau et al., 
2010) and the fifth family is characterized by having the phenylpropanoid (E)-
methylisoeugenol (Figure 8) as a main component (Guinoiseau et al., 2010). 
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Figure 8 - Structures of major components of Daucus essential oil: Carotol (A), Geranyl acetate (B), 
Sabinene (C), (E)-methylisoeugenol (D)  
Carotol rich-oils: Carotol is described as one the major components on both cultivated 
(D. carota subsp. sativus) and wild carrot (different subspecies of D. carota) seed oil. Oils 
from India (70%), Pakistan (62.8-77.5%), Egypt (65.8-67.2%), France (69.7-73.1%) and 
Turkey (68.8%) are described as having a carotol content higher than 60% (Guinoiseau et 
al., 2010). 
Geranyl acetate rich-oils: Geranyl acetate is the major component in essential oils 
distilled from samples from Portugal (65%, D. carota subsp. carota), Spain (51.7-76.9%, D. 
carota subsp. gummifer), Germany and Russia (Guinoiseau et al., 2010). 
Sabinene rich-oils: This compound has been described as the major compound in 
essential oils from Lithuania (28.2-37.5%, D. carota subsp. carota) (Guinoiseau et al., 2010). 
IV. Morphological and chemical characterization of Daucus L. 
29 
 
Oils that contain the three above compounds in an equal ratio: Some oils are 
described as having all three, or at least two out of three, of the reported compounds 
with equal abundance. For example the content on carotol, geranyl acetate and sabinene 
in industrial oil from France is 18%, 17% and 15%, respectively and the contents of carotol, 
geranyl acetate and sabinene in essential oil from D. carota subsp. sativus from Germany 
are 24.1%, 18.3% and 10.1% (Guinoiseau et al., 2010). 
Phenylpropanoid rich-oils: Some oils major components are phenylpropanoids instead 
of terpenes. Essential oil from Lebanese D. carota subsp, maximus is characterized by (E)-
methylisoeugenol  (37.2%) and β-asarone (17.7%), whereas Corsican essential oil is rich in 
(E)-methylisoeugenol  (21.8-41.6%) and elemicin (4.8-16.3%) (Guinoiseau et al., 2010). 
Besides these five most common carrot seed oils, there are some oils that have a 
composition that is characterized by different monoterpenes, such as, geraniol or neryl 
acetate or by sesquiterpenes, e.g. β-bisabolene or γ-bisabolene (Guinoiseau et al., 2010). 
Essential oils that are obtained from aerial parts of the plant (umbels, flowers, stems and 
leaves) have a composition that is, similar to what was described for seed oils, being also 
highly variable between samples (Guinoiseau et al., 2010). In fact, some samples are 
characterised as having sabinene, α-pinene, both monoterpenes, or trans-asarone, a 
member of the phenylpropanoid family (Guinoiseau et al., 2010). Contrarily, most samples 
are described as having a mixture of compounds for instance, carotol/himachalenol/β-
bisabolene or shyobunone/preisocalamendiol (Guinoiseau et al., 2010). 
Very few studies have been carried out using carrot root oils (Guinoiseau et al., 2010). 
Terpinolene has been described as  the major compound in the essential oil from roots 
of D.carota subsp. sativa whereas theoil isolated from roots of wild D. carota subsp. 
maritimus were characterized by two phenylpropanoids, dillapiole (46.6%) and myristicine 
(29.7%) (Guinoiseau et al., 2010).  
Other compounds have also been described for different extracts of Daucus carota 
namely, carotamine (an aromatic peptide) was isolated from an aqueous ethanolic extract 
from the aerial parts of Daucus carota var boissieri (Guinoiseau et al., 2010) and the aqueous 
extracts from seeds were a source of crotonic acid (Jasicka-Misiak et al., 2004). 
Nevertheless, studies regarding the phenolic composition of Daucus carota extracts are 
very sparse and therefore no section on this matter was considered.  
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 The work conducted in this thesis consisted in the evaluation of the bioactive 
properties of both essential oil and phenolic-enriched extracts obtained from Daucus carota 
subsp. carota, commonly known as wild carrot. In this section the extraction techniques used 
as well as the major compounds identified and extraction yields are highlighted. In the following 
sections studies regarding the antibacterial, antifungal, antioxidant and anti-inflammatory 
properties of the essential oil and/or the phenolic-enriched extracts as well as their 
cytotoxicity are presented. 
1.1. Material and methods 
 
1.1.1. Plant material 
Aerial parts of Daucus carota subsp. carota were collected from Serra da Lousã, 
Coimbra, Portugal. The plant material was air dried and then submitted to different extraction 
processes in order to obtain the essential oil (distillation) or phenolic-enriched extracts 
(solvent extraction). 
1.1.2. Distillation and oil characterization 
Hydrodistillation was performed in a circulatory Clevenger-type apparatus according 
to the procedure described in the European Pharmacopoeia during 4 h (Council of Europe, 
2010).  
Chemical characterization of the essential oil from this species was previously conducted in 
our laboratory using both gas chromatography (GC) and gas chromatography-mass 
spectroscopy (GC-MS).  The volatile compounds were identified by their retention indices 
(using SPB-1 and SupelcoWax-10 columns) and their mass spectra. Relative amounts of 
individual components were calculated based on GC peak areas without a FID response factor 
correction, according to Cavaleiro et al (Cavaleiro et al., 2004)(2004).  
1.1.3. Solvent extraction and characterization of the phenolic profile 
Prior to extraction, the dried matter was grounded and10 g of the grounded sample 
was dissolved in 500 mL of three distinct solvents: distilled water, methanol or a 
hydromethanol solution at 70% (v/v). The aqueous extract was obtained using boiling water 
under magnetic agitation for 20 min, while the other two extracts were obtained with 
magnetic agitation at room temperature for 1 h. Extractions were performed twice in the 
same material after a cheesecloth filtration and under the same conditions. Prior to both 
extractions, the extracts were mixed and submitted to evaporation. The solvent was removed 
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in a rotator evaporator under vacuum at 40 ºC and distilled water was added until the solvent 
was thoroughly evaporated to a final volume approximately of 50 mL, followed by freezing and 
lyophilisation. The dried powder material of the distilled water extract (H2O), methanol 100% 
extract (MeOH 100%) and methanol 70% (v/v) extract (MeOH 70%) was separately stored in 
screw-tight flasks and in a desiccator in the dark until further analysis. 
The phenolic profile of the polar extracts were obtained by HPLC-DAD-ESI-MSn, according 
to Catarino et al. (2015). The identification of individual phenolic compounds was achieved by 
comparison of their retention times, UV–Vis spectra and MSn spectra data with those of the 
closest available reference standards and data reported in the literature. The identification of 
those compounds for which no standard compounds were available was achieved only by 
comparison of the data reported in literature. 
1.2. Results 
 
1.2.1. Essential Oil 
1.2.1.1. Identification of the major compounds 
 The essential oil was obtained with a yield of 0.9% (v/w). In table 1 the major 
compounds identified in D. carota subsp. carota essential oil are presented. Amongst them the 
most preeminent is geranyl acetate (29%; Fig 9A) and α-pinene (27%; Fig. 9B). In fact, this 
composition is as expected since the essential oils obtained from wild carrot in the Iberian 
Peninsula belong to the geranyl acetate chemotype, characterized by high amounts of geranyl 
acetate, however other compounds like α-pinene can also be found in significant amounts 
(Guinoiseau et al., 2010). 
CH3
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Figure 9 - Major compounds found in D. carota subsp. carota essential oil: A- geranyl acetate; B- α-pinene 
Table 1 -Main compounds identified in Daucus carota subsp. carota essential oil 
Compound Relative abundance (%) Identification 
geranyl acetate 29 RIa, GC-MS 
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α-pinene 27 RIa, GC-MS 
11αH-himachal-4-ene-1-β-ol 9.2 RIa, GC-MS 
limonene 9 RIa, GC-MS 
a – Retention index determined using SPB-1 and SupelcoWax-10 columns  
  
Previous studies concerning several Daucus carota subspecies have demonstrated that 
the essential oil composition is greatly variable not only amongst subspecies but also when 
different plant origins are compared. Also, the plant part used for oil extraction is an important 
aspect to consider. For example, D. carota subsp. carota mature umbels essential oil from 
Cantanhede (Central Portugal) is characterized by high amounts of geranyl acetate (65%) and 
α-pinene (13%) while Sardinian essential oil is rich in β- bisabolene (51.0%), E-methylisoeugenol 
(10.0%) and 11αH-himachal-4-ene-1-β- ol (9.0%) (Maxia et al., 2009). Moreover, the essential 
oil from leaves and fruits of D. carota subsp. carota growing in Vienna (Austria) is characterized 
by high amounts of α-pinene (20.9 – 44.8%) and sabinene (11.3 – 46.6%) (Chizzola, 2010).  
Regarding different subspecies, the essential oil from ripe umbels of D. carota subsp. 
gummifer from São Pedro de Moel (Portugal) is mainly composed by geranyl acetate (37%), α-
pinene (30.9%) and carotol (11%) (Valente et al., 2015); essential oil obtained from ripe umbels 
of D. carota subsp. halophilus growing in Algarve (Portugal) is rich in elemicin (26.0 – 31.0%) 
and sabinene (27.6 – 29.0%) (Tavares et al., 2008) whereas Tunisian D. carota subsp. maritimus 
flowers yields an essentiall oil that is characterized by high amounts of sabinene (51.6%), 
terpinen-4-ol (11.0%), p-cymene (4.2%) and eudesm-6-en-4-ol (3.6%) (Jabrane et al., 2009). 
 
1.2.2. Phenolic-enriched extracts 
1.2.2.1. Extraction yield and identification of major compounds 
The extraction yields of the different phenolic-enriched extracts are summarized in 
table 2, where it can be observed that the H2O extract is the one with the highest extraction 
yield (23.82%), while MeOH 100% only represented 9.41% of the dried plant material. 
Table 2 - Extraction conditions and yield of the 3 distinct phenolic-enriched extracts 
Sample Extraction Conditions Yield (%) 
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MeOH 100% 
Room temperature with magnetic 
stirring for 1h 
9,41 
H2O 
Boiling water with magnetic 
stirring for 20 min 
23,82 
MeOH 70% 
Room temperature with magnetic 
stirring for 1h 
17,98 
 
The chromatographic analysis of the three phenolic extracts, revealed that the 
composition was very similar between them. In figure 10 a representative chromatogram is 
shown. As seen in table 3, the major compounds identified were caffeoylquinic acid isomers 
(Figure 11A) and dicaffeoylquinic acid isomers (Figure 11B) as hydroxycinnamic acids and rutin 
(Figure 11C) and quercetin-hexoside (Figure 11D) belonging to the flavonoids family. 
 
 
 
 
 
 
 
 
Figure 10 - Representative chromatogram of the D. carota subsp. carota phenolic extracts studied at 280 
nm. CQAi – Caffeoylquinic acid isomer, Rut – Rutin, Quer-hex – Quercetin-hexoside, diCQAi – dicaffeoylquinic acid 
isomer 
  
To the author´s knowledge, studies regarding the phenolic characterization of carrot 
only used roots.  Therefore, the characterization of extracts obtained from the aerial parts 
are herein presented for the first time. Kammerer and colleagues identified in black carrot 
(Daucus carota ssp. sativus var. atrorubens Alef.) root methanolic extract several caffeoylquinic 
acid isomers and well as dicaffeoylquinic acids amongst other hydroxycinnamic acids, however 
they didn’t identify any of the referred flavonols pointed out in the present study (Kammerer 
et al., 2004).  
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Table 3 - Identification of LC-DAD-ESI/MSn of the major components of D. carota subsp. carota extracts 
RT (min) λmax Compound (MW) Main MSn fragments Identification 
1.53 221, 325 354 MS2[353]: 191, 179, 173 Caffeoylquinic acid isomer 
1.94 220, 322 354 MS2[353]: 191, 179, 135 Caffeoylquinic acid isomer 
2.16 221, 316 354 MS2[353]: 191, 179, 173 Caffeoylquinic acid isomer 
2.67 217, 328 354 MS2[353]: 191, 173, 111 Caffeoylquinic acid isomer 
3.54 257, 354 610 MS2[609]: 301 Rutin (quercetin-3-O-rutinoside) 
4.41 256, 351 464 MS2[463]: 301 Quercetin-hexoside 
6.23 215, 327 516 MS2[515]: 353 Dicaffeoylquinic acid isomer 
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Figure 11 - Phenolic compounds found in D.carota subsp. carota extracts. A - Caffeoylquinic acid, B - 
dicaffeoylquinic acid, C - Rutin, D - Quercetin-hexoside 
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2.1. Introduction 
The incidence of bacterial infections has been rising over time due to the increase in 
population’s age, increase in the usage of biomaterials, a higher rate of organ transplantations 
and, most importantly, the increase of bacteria resistance to antibiotics (Oosten, van et al., 
2015). The severity of these infections varies from self-limiting to potentially life-threatening, 
resulting in major morbidity and mortality rates, thus increasing the overall healthcare costs 
(Oosten, van et al., 2015). Since the discovery of penicillin and the following boom in the 
antibiotic field, these drugs have been widely used and were even considered “miracle drugs” 
which led to the belief that bacterial infections were utterly defeated (Penesyan et al., 2015). 
However, the overuse of antibiotics also led to the appearance of even more pathogenic 
bacteria that created resistance to these inhibitory effects. The most common bacterial 
infections are caused by Listeria monocytogenes., Staphylococcus aureus, Salmonella thypimurium, 
Escherichia coli and Bacillus spp.. A brief summary of these infections regarding their causal 
agent, main symptoms and current treatment is presented. 
i) Listeriosis 
This infection is caused by the Gram-positive bacterium Listeria monocytogenes, a 
foodborne pathogen described in 1980 (Noordhout et al., 2014). In 2000, the prevalence of 
this disease, in the USA, was of 4 per million inhabitants. In Europe this number varies from 
0.1 to 11.3 per million inhabitants, and circa 20% are neonatal infections (Lamont et al., 2011). 
Infections by L.. monocytogenes in healthy patients may cause febrile gastroenteritis which 
typically is mild and self-limiting. However, when the patient belongs to a risk group (pregnant 
women, elderly, immunocompromised person, unborn babies or neonates), listeriosis may 
cause several illnesses, e.g. severe sepsis, meningitis or encephalitis which lead to lifelong 
consequences or, in the most severe cases, death (Noordhout et al., 2014). The reported 
cases of listeriosis are divided into three clinical syndromes: maternofetal listeriosis, blood 
stream infection and meningoencephalitis (Hernandez-Milian et al., 2014; Swaminathan et al., 
2007). The fatality rate of this bacterial infection is about 20-30% of the cases despite 
availability of adequate treatment (Swaminathan et al., 2007).  
The first-line treatment for L.. monocytogenes infections is a β-lactam antibiotic, usually 
ampicillin. Since penicillin-derived antibiotics are known to be bacteriostatic, some treatments 
employ combinations with other compounds such as aminoglycosides (e.g. gentamicin) 
(Hernandez-Milian et al., 2014; Swaminathan et al., 2007).  
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ii) Staphylococcus aureus infections 
Staphylococcus aureus is a commensal yet pathogenic Gram-positive bacterium. Nearly 
30% of the population is colonized by this bacteria (Lister et al., 2014; Tong et al., 2015). This 
pathogen is the preeminent cause for bacteraemia and infective endocarditis in addition to 
osteoarticular, skin and soft tissue, pleuropulmonary and device-related infections (Tong et al., 
2015).  
S. aureus bacteraemia is the best described infection. This disease has an incidence of 
10-30 per 100000 person-year in the industrialized world, while in the non-industrialized word 
the incidence is still unknown due to the lack of population-based studies (Tong et al., 2015). 
The risk factors for this pathogeny is age, with higher incidence in the first year of life and with 
advanced aging; the gender is also important with a ratio male-to-female of approximately 1.5, 
with the reason for this difference   remaining unknown (Tong et al., 2015). Ethnicity is also an 
important factor however, the reason for this is not fully explained. Likewise, HIV infection is 
a very significant risk factor with HIV-infected patients having an incidence 24 times greater 
than non-HIV-infected patients (Tong et al., 2015). Haemodialysis patients also have a greater 
risk of contracting S. aureus bacteraemia (Tong et al., 2015). In cases of bacteraemia caused by 
methicillin-sensitive S. aureus, the first-line therapy consists of β-lactam antibiotics while in 
cases of methicillin-resistant S. aureus the therapy is based upon vancomycin and daptomycin 
(Tong et al., 2015).  
iii) Salmonellosis 
Salmonella enterica serovar typhimurium (S. typhimurium) is a Gram-negative bacterium 
that causes severe inflammation of the intestinal mucosa which leads to gastroenteritis (Patel 
et al., 2014). This serovar as well as others that cause non-typhoidal Salmonella infections, are 
primarily transmitted in industrialized countries by food contaminated with animal feces (Bula-
Rudas et al., 2015; Crump et al., 2015; Kariuki et al., 2015). However, it can also be transmitted 
by direct contact with infected animals, e.g. reptiles, amphibians, live poultry, and pet rodents 
(Bula-Rudas et al., 2015; Crump et al., 2015). The prevalence of these syndromes worldwide 
is thought to be 93.8 million cases of which 155000 result in death (Kariuki et al., 2015). These 
infections, in immunocompetent and healthy patients, normally cause a self-limiting 
enterocolitis with diarrhoea (Bula-Rudas et al., 2015; Crump et al., 2015; Kariuki et al., 2015). 
However, approximately 6% of the cases lead to bloodstream infections, being the risk higher 
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in some groups, e.g. immunocompromised individuals, infants, and elderly people (Crump et 
al., 2015; Kariuki et al., 2015). 
The usage of antimicrobial agents to treat cases of Salmonella infections is dependent 
on the local epidemiology and the resistance pattern of the infectious agent. The most used 
agents are ampicillin, amoxicillin, tetracycline, macrolides, trimethoprim-sulfamethoxazole, 
chloramphenicol and fluoroquinolones (Bula-Rudas et al., 2015).  
iv) Escherichia coli infections 
E. coli is a Gram-negative bacterium that belongs to the Enterobacteriaceae family. This 
is a commensal bacterium in the gastrointestinal tract that normally is harmless to the host. 
However,  E. coli has several serotypes that are highly pathogenic and responsible for infections 
in the gastrointestinal tract as well as in the extraintestinal locals such as the urinary tract, 
bloodstream and central nervous system (Croxen et al., 2013).  
In turn enteric E.coli is responsible for diarrhoea, however the type of diarrhoea as well 
as the associated symptoms, outcomes, sites of infection and disease can differ. There are 
seven described pathotypes of enteric E. coli, namely enteropathogenic, enterohemorragic, 
enterotoxigenic, enteroagregative, diffusely adherent, enteroinvasive and adherent invasive E. 
coli (Allocati et al., 2013; Bettelheim et al., 2015; Croxen et al., 2013).  
The pathogenic serotypes can be divided into enteric E. coli or extraintestinal E. coli. 
The latter are responsible for infections outside the gastrointestinal tract, of which one 
pathotype causes lower urinary tract and systemic infections and is known as uropathogenic 
E. coli, the other infects the central nervous system causing neonatal meningitis being known 
as neonatal meningitis E. coli and the third is known as avian pathogenic E. coli, because it is 
thought to cause a foodborne disease (Allocati et al., 2013). 
The treatment of E. coli infections, both enteric and extraintestinal, is normally achieved 
by oral rehydration therapies, however in some persistent cases antimicrobial therapy may be 
needed (Croxen et al., 2013). In these cases, the therapy requires the administration of first-
line antibiotics such as ampicillin, trimethoprim-sulfamethoxazole, tetracyclines and 
fluoroquinolones (Kong et al., 2015).  
v) Bacillus spp. 
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Bacillus subtilis is a Gram-positive bacterium that is ubiquitous in soil and gastrointestinal 
tract. This species is only pathogenic in immunocompromised patients. In healthty patients, 
the species can be used to restore the balance in the microbial flora in the intestinal tract 
(Oggioni et al., 1998). Due to this, the section regarding B. subtilis is not as exhaustive as the 
remaining pathogenic bacteria. 
 
The boost of bacterial resistance to conventional antibiotics has encouraged scientists 
to discover new antibacterial agents with a broader spectrum of action (Nazzaro et al., 2013). 
Since immemorial times, plant-derived products, such as essential oils and phenolic-enriched 
extracts, have been used in folk medicine to control bacterial infections (Dorman et al., 2000; 
Faleiro M.L., 2011; Nazzaro et al., 2013). Several authors have described the antibacterial 
activity of essential oils and their isolated compounds against different pathogenic bacteria (e.g. 
Chalchat et al., 2000; Filipowicz et al., 2003; Sonboli et al., 2005). The mechanism of action that 
causes the bacteriostatic and/or bactericidal effects of essential oils have also been described 
by some authors (Dorman et al., 2000; Nazzaro et al., 2013). These studies have demonstrated 
that Gram-negative bacteria are more resilient to essential oils than Gram-positive ones 
(Nazzaro et al., 2013). This susceptibility of Gram-positive bacteria may be explained by 
differences in the cell wall composition. It is known that 90-95% of the cell wall in Gram-
positive bacteria is peptidoglycan which allows hydrophobic compounds to penetrate the cell 
and act on the cell wall as well as on the cytoplasm (Nazzaro et al., 2013). Conversely, the cell 
wall in Gram-negative bacteria is far more complex. In these bacteria the cell wall- 
peptidoglycan is only 2-3 nm thick and is bounded to an outer membrane (Nazzaro et al., 
2013). This outer membrane is a bilayer of phospholipid and several proteins amongst which 
the lipopolysaccharide is a good example and very important to bacteria virulence. The outer 
membrane is almost fully impermeable to hydrophobic compounds (e.g. essential oils) 
however some compounds can slowly enter the cell via the abundant porins found on the 
membrane (Nazzaro et al., 2013). Both the presence of lipopolysaccharide and the 
impermeability to hydrophobic compounds are responsible for the resistance to essential oils 
and other antimicrobial agents (Nazzaro et al., 2013). However this resistance can be 
overcome by permeabilisers, compounds (e.g. small terpenoids and phenolic compounds) that 
are able to disrupt the outer membrane by disintegrating the lipopolysaccharide layer 
(Puupponen-Pimiä et al., 2005).  
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2.2. Material and Methods  
2.2.1. Essential oil, phenolic-enriched extracts and reference compound 
The essential oil from Daucus carota subsp. carota and the 70% methanol phenolic-
enriched extract were used to determine the antibacterial activity of this species. Regarding 
the phenolic extracts, their chemical composition was very similar with minor quantitative 
differences. Thus, their bioactivity is expected to be similar and, in the present study, only one 
of the phenolic-enriched extracts (70% methanol) was selected to evaluate the antibacterial 
and antifungal activities.The reference compound used was the antibiotic ampicillin purchased 
as Ampicillin sodium salt from Fluka BioChemika (Buchs, Switerzland) 
2.2.2. Bacterial strains 
The antibacterial activity was carried out against both Gram-negative and Gram-
positive bacteria. Most of these strains were obtained from the American Type Culture 
Collection (Salmonella thyphimurium ATCC 14028; Staphylococcus aureus ATCC 6538; 
Escherichia coli ATCC 25922; Bacillus subtilis ATCC 6633), one strain was obtained from the 
Coleção de Bactérias do Instituto Superior de Agronomia (Listeria monocytogenes CBISA 3183) and 
one was isolated from meat (Bacillus subtilis). 
2.2.3. Antibacterial activity  
The macrodilution method was used for the determination of the Minimum Inhibitory 
Concentration (MIC) and Minimum Lethal Concentration (MLC) of both the essential oil and 
the phenolic-enriched extract as described in the CLSI reference M07-A9 (CLSI, 2012). Briefly, 
serial doubling dilutions of the oil were prepared in dimethyl sulfoxide (DMSO, Sigma Life 
Science, Sigma-Aldrich, MO, USA)). Dilutions ofethe phenolic-enriched extract were prepared 
in Mueller Hinton broth (Oxoid, Hampshire, England), with concentrations ranging from 0.08 
to 20 μL/mL. Recent cultures of each strain were used to prepare the cell suspensions (1.2x105 
CFU/mL)) and cells concentration was confirmed by viable count on Mueller Hinton Agar 
(Oxoid, Hampshire, England). All tests were performed in Mueller Hinton Broth medium and 
the test tubes were incubated aerobically at 37 °C for 24h and then MICs were registered. To 
evaluate MLCs, 20 μL of broth were taken from each negative tube after MIC reading, and 
cultured in Mueller Hinton Agar plates and then incubated as referred above. Mueller-Hinton 
broth sterility was also evaluated for each strain. DMSO innocuity was also determined. All 
tests were performed in duplicate. The results are shown as mean of three independent 
experiments. 
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2.3. Results and Discussion 
 
2.3.1. Antibacterial activity of the essential oil 
Table 4 respresents the MIC and the MLC values of the essential oil and methanolic 
extract of Daucus carota subsp. carota against several bacterial strains. As expected, the 
essential oil demonstrated a stronger inhibitory effect against Gram positive bacteria (MIC 
0.32-0.64 µL/mL) than against Gram negative positive bacteria (>10 µL/mL). The Gram positive 
bacteria S. aureus and both B. subtilis strains showed a higher susceptibility to the essential oil’s 
inhibitory effect (MIC 0.32 µL/mL and MLC 0.64 µL/mL).  
 
Table 4. Antibacterial activity (MIC and MLC) of essential oil and MeOH 70% extract of Daucus carota 
subsp. carota for several bacterial strains. 
Strains 
Essential Oil MeOH 70% Ampicillin 
MICa MLCa MICb MLCb MICc MLCc 
Bacillus subtilis (isolated from meat) 0.32 0.64 5 10 0.06 4 
Bacillus subtilis ATCC 6633 0.32 0.64 5 10 0.06 0.025 
Escherichia coli ATCC 25922 >10 >10 >10 >10 8 16 
Listeria monocytogenes CBISA 3183 0.64 >10 >10 >10 2 16 
Salmonella thyphimurium ATCC 14028 >10 >10 >10 >10 4 8 
Staphylococcus aureus ATCC 6538 0.32 0.64 5 10 0.25 0.5 
a MIC and MLC were determined by a macrodilution method and expressed in µL/mL. 
b MIC and MLC were determined by a macrodilution method and expressed in mg/mL. 
c MIC and MLC were determined by a macrodilution method and expressed in µg/mL. 
Results were obtained from three independent experiments performed in duplicate. 
 
The results obtained for Daucus carota subsp. carota essential oil (rich in geranyl acetate, 
α-pinene and limonene) are quite interesting since it has been reported that essential oils rich 
in ketones and esters (e.g. α-thujone, geranyl acetate) retain a weak antibacterial activity. In 
fact, previous studies have demonstrated that geranyl acetate has a rather low growth 
inhibition against a wide range of bacteria both Gram negative and Gram positive (Dorman et 
al., 2000; Kakarla et al., 2009). Also, limonene, a cyclic terpene, demonstrated a very weak 
activity against several bacterial strains, e.g. S. aureus, E. coli, and B. subtilis (Caven-Quantrill et 
al., 2007; Dorman et al., 2000; Filipowicz et al., 2003; Sonboli et al., 2005; Verbenaceae et al., 
2006). Conversely, α-pinene, a monoterpene found in many essential oils, showed a strong 
effect on the inhibition of the growth of a wide variety of bacteria (Dorman et al., 2000; 
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Filipowicz et al., 2003; Orhan et al., 2012; Verbenaceae et al., 2006). Although the activity of 
geranyl acetate and limone are weak, α-pinene has a very good activity, thus the activity of D. 
carota subsp. carota essential oil might be explained by the high amounts of α-pinene (27%). 
The differences observed between the activity of isolated compounds and the whole essential 
oil might be due to the presence of minor compounds that can einfluence the activity of α-
pinene. 
2.3.2. Antibacterial activity of the hydromethanolic extract 
The antibacterial activity of the methanol 70% (v/v) extract was weaker than that 
described for the essential oil however the pattern was similar i.e., Gram negative bacteria 
(MIC>10 mg/mL) were more resilient than Gram positive ones (MIC 5 mg/mL). Similarly to 
what was described for the essential oil, the bacteria S. aureus and both B. subtilis strains were 
the most susceptible to the extract (MIC 5 mg/mL and MLC 10 mg/mL).  
Considering previous studies on the major compounds of this extract: caffeoylquinic 
acid isomers, rutin, quercetin-hexoside and dicaffeoylquinic acid, some studies have been 
conducted. Namely, 3-/4-/5-Caffeyolquinic acid showed a MIC ranging from 0.1-0.2 mg/mL 
against S. aureus and E. coli (Xia et al., 2011). In another study, 5-Caffeyolquinic acid 
demonstrated a MIC of 5-10 mg/mL against S. aureus and E. coli (Bajko et al., 2015). The 
flavonoid glycoside, rutin (quercetin-3-O-rutinoside) was able to inhibit S. typhimurium and E. 
coli (Srinivas et al., 2012). At 50 µg this flavonoid showed an inhibition zone of 0.6 mm for S. 
aureus (Soberón et al., 2014). The MIC of rutin for E. coli, S, aureus and B. subtilis ranged from 
4 to 16 mg/mL (Orhan et al., 2010; Wang et al., 2013). Therefore, the activity of the isolated 
major compounds D. carota subsp. carota hydromethanolic extract is weaker than the extract 
per se. This difference might be explained by the presence of minor phenolic compounds that 
synergistically work with these major compounds. 
The antibacterial activity of Daucus carota has also been described for isolated 
compounds from other aromaticextracts in addition to those found in theessential oil 
(Bergonzelli et al., 2003; Glisic et al., 2007; Rossi et al., 2007; Staniszewska et al., 2005). 
 Carrot fruit supercritical fluid extract as well as the essential oil (major components 
carotol and sabinene) are described as having a minimum inhibitory concentration (MIC) 
ranging from 80 to 1280 µg/mL for Gram positive bacteria (S. aureus, B. cereus, and B. subtilis 
Rhodococcus equi, Listeria monocytogenes and Enterococcus faecalis) while for Gram negative 
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bacteria the MIC is higher than 1280 µg/mL (E. coli, P. aeruginosa and Salmonella enteritidis) 
(Glisic et al., 2007; Guinoiseau et al., 2010). Similarly, oils from herb, flowering and mature 
umbels demonstrate a higher inhibitory effect against Gram positive than against Gram 
negative bacteria (Guinoiseau et al., 2010; Staniszewska et al., 2005).  
Oils obtained from flowers and roots of D. carota subsp. maritimus were also described 
as having a bactericidal activity against Gram negative strains, Pseudomonas aeruginosa, E. coli, 
Klebsiella  pneumoniae and S. typhimurium (MIC ranging from 1.25 to 5 g/L). Flower oil 
dominated by sabinene (51.6%), terpinen-4-ol (11.0%) and eudesm-6-en-4-ol (3.6%) had a 
higher inhibitory activity against E. coli growth when compared with root oils. Conversely, root 
oil majorly constituted by two phenyl propanoids, dillapiole (46.6%) and myristicine (29.7%), 
was more active than flower oil against S. pneumonia and Shigella spp. (Jabrane et al., 2009). 
The results obtained in the present study are quite promising for infections caused by 
Gram positve bacteria since these bacteria are more susceptible to the action of both Daucus 
carota subsp. carota essential oil and phenolic-enriched extract.  
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3.1. Introduction  
Fungi are the causative agent on several and serious pathogenic infections whose 
prevalence has increased over the last decades, with particular focus on high-risk patients 
(Muñoz et al., 2012; Pfaller et al., 2006; Sipsas et al., 2012; Zuzarte, 2012). The severity of fungal 
infections is dependent on the virulence of the strain, the host reaction to the metabolites 
synthetized by the fungi, the local of infection along with some environmental factors (Romani, 
2007; Weitzman et al., 1995; Zuzarte, 2012). Fungal infections are often disfiguring, recurrent 
and chronic and normally imply long-term treatments (Shehata et al., 2008). These infections 
can be treated by a wide range of commercially available antifungal agents.  Nevertheless, the 
increased resistance of several strains to antifungals and associated side effects, ranging from 
mild reactions to hepatotoxicity, neurotoxicity, nephrotoxicity and hematologic reactions, are 
responsible for unsuccessful treatments (Andriole, 2000; Gupta et al., 2008; Rosso, 2000; 
Zuzarte, 2012). Candidosis, cryptococcosis, dermatophytosis and aspergillosis are exemples 
of the most common and most threatening fungal infections that are even more threatening 
on immunocompromised patients (Zuzarte, 2012). A brief summary on these infections 
pointing out their casual agents, symptoms and treatments is presented. 
i)  Candidosis 
This fungi-related disease outcomes when the host suffers an infection from yeasts of 
the genus Candida (Zuzarte, 2012). These species are commensal microorganisms of the oral 
cavity, gastrointestinal tract and vagina (Mårdh et al., 2003, 2002). In the last few years, the 
number of Candida infections have significantly increased, being C. albicans, C. glabrata and C. 
parapsilosis the main agents of nosocomial fungal bloodstream infections (Hajjeh et al., 2004). 
The most common manifestation of these infections is vulvovaginal candidosis, affecting 70-
75% of women and it is a recurrent infection in 40-50% of the cases (Costa-De-Oliveira et al., 
2008). The main symptoms of vulvovaginal candidosis include vaginal irritation, vulvar burning, 
pruritus and vaginal discharge (Palmeira-de-Oliveira et al., 2009; Zuzarte, 2012). The last years 
have also seen an increase in recurrence cases of vulvovaginal candidosis, being associated to 
relapses of persistent strains after long-term treatments (Murina et al., 2011; Zuzarte, 2012). 
This disease has several risk factors that increase the chances of contracting it, the most 
preeminent and common factors are, pregnancy, diabetes mellitus, oral contraceptive use, 
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antibiotics, tight-fitting cloths, synthetic underwear, dietary excesses or deficiencies, intense 
sexual activity and the use of female hygiene products (Sobel, 2007). 
Only a few of the commercially available antifungals are effective against Candida spp. 
infections, with amphotericin B, fluconazole and itraconazole being the most widely used 
(Carrillo-Muñoz et al., 2006).  
ii) The pathogenic mechanisms behind Candida infections are still unclear but have been 
associated to germ tube formation. Blastoconidia are involved in asymptomatic 
colonization of the vagina, while germ tube and hyphae are found on symptomatic 
cases of these infections. In addition, the organization in biofilms are thought to be 
responsible for the observed resistance to several antifungal agents thus reducing the 
effectiveness of these drugs (Kuhn et al., 2002). This resistance is assumed to be 
associated with phenotypic modifications on fungal cells alongside with expression of 
resistance genes that occur during biofilm formation (Chandra et al., 2001; Douglas, 
2003). Hence, germ tube inhibition and/or disruption of biofilm organization appear 
to be a promising target for the control of these infections, avoiding dissemination of 
the infectious agent.Cryptococcosis 
Cryptococcosis is an invasive fungal infection caused by yeasts of the genus 
Cryptococcus, mainly C. neoformans and C. gattii. Clinical manifestations of this type of infection 
range from asymptomatic infection to severe pneumonia and respiratory failure (Brizendine et 
al., 2011). Managing this disease can be rather difficult as the treatment, which can be either 
with amphotericin B, flucytosine or fluconazole, varies with the characteristics of the affected 
population (HIV-seropositive, organ transplant recipients or non-transplant/non-HIV) 
(Desalermos et al., 2012). Immunocompromised patients are a higher risk group as the 
infection by Cryptococcus may spread to the brain leading to neurological disturbances such as 
meningoencephalitis (Lin et al., 2006), a disease responsible for more than 600,000 deaths per 
year worldwide (Desalermos et al., 2012). 
 
iii) Dermatophytosis  
Fungi from the genus Trichophyton, Microsporum and Epidermophyton are responsible for 
common infections of keratinized tissues (skin, hair and nails) of both humans and animals 
usually called dermatophytosis (Dahdah et al., 2008; Hainer, 2003; Shehata et al., 2008). The 
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infection caused by these fungi may vary from mild to very intense. These infections are 
normally non-invasive, however in immunocompromised patients they can rapidly progress to 
life-threating infections (Zuzarte, 2012). Moreover, zoophilic and geophilic dermatophytes are 
accountable for severe inflammatory reactions owed to delayed hypersensitivity responses to 
fungi proteases. Additionally, pediatric and geriatric populations have seen an increase in the 
number of infections by these agents (Monod, 2008; Mukherjee et al., 2003). 
Cutaneous dermatophytosis are recognized by their scaly patches, with central clearing 
and sharply demarcated, annular, erythematous, advancing margins, sometimes presenting 
vesicles, blisters and pustules (Dahdah et al., 2008). Distinction between these infections and 
other clinical conditions with similar symptomatology (e.g. nummular eczema, subacute 
cutaneous lupus erythematosus, herpes simplex, varicella zoster virus) is not an easy task 
(Ziemer et al., 2007).  
Prescribed drugs for dermatophytosis includes both oral and topical formulations, that 
derive from two antifungal drug families: azoles (e.g. clotrimazole, miconazole) and allylamines 
(e.g. terbinafine and naftifine) (Gupta et al., 2008; Zuzarte, 2012). Superficial mycosis such as  
tinea pedis, tinea mannum, tinea corporis and tinea crurise normally respond to topical treatments 
(Andrews et al., 2008; Dahdah et al., 2008; Gupta et al., 2008). Amorolfine and butenafine, 
derivatives from morpholine, have also been described as antifungal agents (Gupta et al., 2008). 
In cases where the infection area is too wide or the infections are severe or persistent, 
systemic therapies should be considered. This is also true for tinea unguium and tinea capitis 
against which terbinafine, itraconazole, fluconazole, griseofulvin and ketoconazole have been 
deemed more adequate. Nevertheless, systemic formulations may present major side-effects 
including hepatotoxicity, neurotoxicity, nephrotoxicity and hematologic reactions, and in some 
cases, uncommon skin problems may appear (Andrews et al., 2008; Gupta et al., 2008; Zuzarte, 
2012). In addition, drug interactions must also be evaluated since they are responsible for the 
reduced effectiveness of these therapies (Andriole, 1999; Rosso, 2000). 
iv) Aspergillosis 
When Aspergillus spp. infect the alveolar tissues in the lungs the resultant disease is 
known as aspergillosis. These diseases include pulmonary aspergilloma, invasive aspergillosis 
and allergic bronchopulmonary aspergillosis (Khan et al., 2011). A. fumigatus and A. niger are 
the main strains responsible for aspergillosis, while A. flavus and A. clavatus are considered less 
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harmful. Invasive aspergillosis is becoming a key health concern as it frequently leads to the 
death of immunocompromised patients (Pfaller et al., 2010). The significance of this condition 
has been growing with the increased numbers of patients with impaired immune system due 
to several conditions (e.g. cancer, organ transplantation) alongside with those with chronic 
obstructive pulmonary disease (Kousha et al., 2011). Furthermore, the resistance of Aspergillus 
strains to antifungal compounds has increased over the last 20 years since its usage has also 
become more disseminated (Hadrich et al., 2012). Voriconazole and amphotericin B 
deoxycholate are the most commonly used antifungal drugs in these cases (Walsh et al., 2008). 
Likewise, food, commodities and raw materials are vulnerable to contamination by 
Aspergillus spp., a major cause of food spoilage, particularly in tropical countries as these fungi 
produce mycotoxins (Hedayati et al., 2007; Whitfield, 2003; Zuzarte, 2012).  They are able to 
cause food decomposition and produce allergenic compounds that might occur before evident 
fungal growth (Pirbalouti et al., 2011).  
Given that the incidence of fungal infections has increased worldwide, there is an 
urgency to search for more effective and less toxic antifungal agents as alternatives to the 
synthetic ones. For centuries, essential oils have been extensively used as antifungals in 
traditional remedies (Ríos et al., 2005). Recently, several studies have corroborated the huge 
potential of these products as antifungal agents (Bakkali et al., 2008; Pina-Vaz et al., 2004; Pinto 
et al., 2006; Reichling et al., 2009). Hence, it is not surprisingly that essential oils are an 
important group of natural products that can be used for the development of broad-spectrum, 
safer and cheaper antifungal agents. Although many studies report the antifungal activity of 
essential oils, the interactions between the oil and the microorganism, which are responsible 
for the inhibitory activity, are still poorly understood. In fact, studies regarding the mechanism 
of action of oils and extracts are sparse, thus hampering its potential utilization for industrial 
processes.  
Although some studies regarding the antifungal activity of D. carota subsp. carota 
essential oil have already been conducted, the mechanism of action underlying the inhibitory 
effect is still greatly unknown. Hence, the aim of this study is to f demonstrate the inhibitory 
effects on fungi [yeasts (Candida spp. Cryptococcus neoformans), dermatophytes (Trichophyton., 
Microsoporum and Epidermophyton species) and other filamentous fungi (Aspergillus spp.)] as well 
as to elucidate the mechanism of action underlying the antifungal effect by studying the 
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inhibitory capacity of the essential oil on C. albicans germ tube formation as well as its effect 
on preformed C. albicans biofilms. 
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3.2. Materials and Methods 
 
3.2.1. Essential oil, phenolic-enriched extracts and reference compounds  
The essential oil and the phenolic-enriched extract (MeOH 70%) used in the antifungal 
activity assay are the same as described in the previous section (2. Antibacterial activity). The 
reference compounds used were Fluconazole, provided by Pfizer as the pure powder and 
amphotericin B purchased from Sigma (80.0% purity).  
3.2.2. Fungal strains 
The antifungal activity of essential oils and phenolic-enriched extract was tested against 
yeasts and filamentous fungi: three Candida reference strains were obtained from the American 
Type Culture Collection (C. albicans ATCC 10231; C. tropicalis ATCC 13803; C. parapsilosis 
ATCC 90018) and two clinical strains were isolated from recurrent cases of vulvovaginal 
candidosis (C. krusei H9; C. guillermondii MAT23); one Cryptococcus neoformans reference strain 
was from the Colección Española de Culturas Tipo (C. neoformans CECT 1078); four 
dermatophytes strains were obtained from the Colección Española de Culturas Tipo (T. 
rubrum CECT 2794; T. mentagrophytes var. interdigitale CECT 2958; T. verrucosum CECT 2992; 
M. gypseum CECT 2908), the remaining dermatophytes were clinically isolated from nails and 
skin (T. mentagrophytes FF7; M. canis FF1; E. floccosum FF9); two reference Aspergillus  strains 
were obtained from the American Type Culture Collection (A. niger ATCC 16404 and A. 
fumigatus ATCC 46645) and one Aspergillus strain was from a clinical origin and was obtained 
from bronchial secretions (A. flavus F44). All strains were cultured in Sabouraud Dextrose 
Agar (SDA) or Potato Dextrose Agar (PDA) before each test in order to ensure optimal 
growth conditions. 
3.2.3. Antifungal activity 
The macrodilution method was used to determine the Minimum Inhibitory Concentration 
(MIC) and Minimum Lethal Concentration (MLC) of the essential oil and the phenolic-enriched 
extract as described in the CLSI references M27-A3 (CLSI, 2008) and M38-A2 (CLSI, 2008) 
for yeasts and filamentous fungi, respectively. Briefly, serial doubling dilutions of phenolic-
enriched extract and essential oil were made on RPMI 1640 broth (with L-glutamine, without 
bicarbonate, pH 7.0, BioChrom Ag., Berlin, Germany) or dimethyl sulfoxide (DMSO, Sigma-
Aldrich, MO, USA), respectively, with concentrations ranging from 10 to 0.02 µL/mL for the 
essential oil and 10 to 0.02 mg/mL for the phenolic extract. Recent cultures of each strain 
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were used to prepare the cell suspensions (1-–2 × 103 cells/mL for yeasts and 1-–2 × 104 
cells/mL for filamentous fungi) and cells concentration was confirmed by viable count on 
Sabouraud agar (Oxoid, Hampshire, England). All tests were performed in RPMI medium and 
the test tubes were incubated aerobically at 35 °C for 48 h/72 h (Candida spp. and Aspergillus 
spp./Cryptococcus neoformans) and at 30 °C for 7 days (dermatophytes) and then MICs were 
registered. To evaluate MLCs, 20μL of broth were taken from each negative tube after MIC 
reading, and cultured in Sabouraud dextrose agar plates and then incubated as referred above. 
RPMI sterility and DMSO innocuity were evaluated for each strain. All tests were performed 
in duplicate and the results are shown as the mean value of three independent 
experiments.3.2.4. Mechanism of action 
 The mechanism of action underlying the inhbibitory effect of the the essential oil on 
yeast virulence factors was considered by evaluating the effect of the oil on the germ tube 
formation of C. albicans as well as its  effect on preformed biofilms. 
3.2.4.1. Inhibition of germ tube formation 
The capability to inhibit the formation of the germ tube on C. albicans was tested for 
the essential oil accordingly to the method described by Pinto and colleagues (Pinto  et al., 
2009). The essential oil’s serial doubling dilutions were made on DMSO starting on the MIC 
and 10µL of each dilution was added to sterile test tubes. The yeast C. albicans after an 
overnight incubation on SDA at 35ºC was suspended on NYP medium (N-acetyl-D-
glucosamine (Sigma) 10-3 M; Yeast Nitrogen Base (Difco) 3.35 g/L; Proline (Fluka) 10.3 M; NaCl 
4.5 g/L, pH 6.7±0.1) and adjusted to the turbidity of the tube 0.5 of McFarland Scale (1.5 x 106 
cells/mL). Then 990µL of inoculated NYP was added to the test tubes that were incubated for 
3h at 37ºC. Following this period 100 cells were counted on a haemocytometer and non-
filamentous cells were distinguished from filamentous ones. Filamentous cells are 
characterized by a cylindrical filament where no constriction is observed on its base.  All the 
cells that failed to exhibit these characteristics were considered non-filamentous. The 
innocuity of DMSO was tested and all tests were performed in duplicate. Results are shown 
as a mean ± standard deviation of three independent determinations. 
3.2.4.2. Effect on preformed C. albicans biofilm 
The effect of the essential oil on preformed C. albicans biofilm was evaluated using the 
method described by Taweechaisupapong (Taweechaisupapong et al., 2012) with some 
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modifications. Briefly, a loop of SDA culture of C. albicans ATCC 10231 grown for 24h at 37ºC 
was suspended in Yeast Peptone Dextrose (YPD) broth (1% yeast extract, 2% peptone, 2% 
dextrose) and was incubated for 24h at 37ºC. The YPD was removed and the cells were 
thoroughly washed twice with sterile PBS pH 7.4 (0.8% NaCl, 0.02% KH2PO4, 0.31% Na2HPO4· 
12H2O, 0.02& KCl). Between each washing step the suspension was submitted to 
centrifugation for 10 min at 3000g. Cell density was adjusted to approximately 1x106 CFU/mL 
which was confirmed by cell counting in a haemocytometer. Then, 100 µL was added to 
selected wells in a 96-well microtiter plate and was incubated for 24h at 37ºC. Then, the wells 
were washed three times with PBS pH 7.4. 100 µL of essential oil double serial dilutions (10 – 
1.25 µL/mL) prepared in RPMI was added to the selected wells and incubated for a further 
24h at 37ºC. Negative and positive controls were also prepared by adding sterile RPMI broth 
and inoculated RPMI broth into selected wells. Results are shown as mean ± standard deviation 
of three independent determinations. All determination were made in duplicate. 
3.2.4.2.1. Biofilm mass quantification by crystal violet assay 
The biofilm mass quantification using crystal violet assay was executed based upon the 
method described by Raut (Raut et al., 2013) with some modifications. Briefly, at the end of 
the steps described above the medium was removed and the cells were fixated to the well 
with 99% methanol for 15 min. The supernatant was removed and the wells were air-dried 
for 1-2 min. 100 µL of 0.02% crystal violet (CV) solution was added and left to stain the cells 
for 15 min. The excess of CV was removed by washing the wells 2-3 times with distilled and 
sterile water. Absorbed stain was released from cells with 150 µL of 33% acetic acid and the 
mixture was transferred to new wells. Optical density (OD) was registered at 620 nm on a 
microtiter plate reader. Biofilm mass was determined by comparing the OD of treated samples 
with the OD of control. Results are presented as mean ± standard deviation of three 
independent determinations performed in duplicate. 
3.2.4.2.2. Biofilm viability by XTT metabolization assay 
This viability assay was perfomed as described by Saharkhiz (Saharkhiz et al., 2012) with 
some modifications. Briefly, by the end of the procedure described in section 3.2.4.2. the 
medium was removed and the wells were thoroughly washed with PBS pH 7.4. To a 1 mg/mL 
solution of XTT, menadione (10 mM in acetone) was added to a final concentration of 4 µM. 
100 µL of this final solution was added to the selected wells that were incubated for 2h at 
37ºC in the dark. The absorbance was read at 490 nm and biofilm viability was determined by 
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comparing the absorbance of treated samples with those of untreated ones. Results are shown 
as mean ± standard deviation of three independent determinations performed in duplicate. 
3.2.5. Statistical analysis  
 The statistical analysis comparing the control group with the different treatment groups 
was performed using an ordinary one-way ANOVA with Dunnett’s multiple comparison test 
with significance levels *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. These tests were 
conducted in GraphPad Prism version 6 (GraphPad Software, San Diego, CA, USA). 
 
3.3. Results and discussion  
3.3.1. Essential oil 
3.3.1.1. Antifungal activity 
The antifungal activity (MIC and MLC) of the essential oil for all tested fungal strains is 
summarized in table 5. The most susceptible fungal strain tested was Cryptococcus neoformans 
with a MIC and MLC of 0.16 µg/mL. For Candida species, the MIC ranged from 0.32 to 5 µL/mL 
while MLC varied from 0.32 to >10 µL/mL. The most susceptible strain was C. guillermondii 
(MIC and MLC of 0.32 µL/mL). For dermatophytes MIC ranged between 0.32 and 0.64 µL/mL 
and MLC oscillated between 0.32 and 1.25 µL/mL, being E. floccosum and T. rubrum the most 
susceptible (MIC and MLC = 0.32 µL/mL). The essential oil was able to inhibit the growth of 
A. fumigatus and A. niger (MIC = 2.5 and 1.25, respectively) however at the tested 
concentrations it failed to kill the fungi. Against A. flavus the oil was ineffective at all the tested 
concentrations. Since the values of MIC and MLC are the same for most of the strains it can 
be said that the essential oil had a fungicidal activity against those strains.
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As far as we know, only one study has been conducted reporting the antifungal activity 
of D. carota subsp. carota essential oil against Candida spp., Cryptococcus neoformans, E. floccosum, 
Trichophyton spp., Microscoporum spp. and Aspergillus spp. (Maxia et al., 2009). In this study the 
essential oil composition was similar to that reported in the present study (geranyl acetate 
and α-pinene as major compounds) however α-pinene was more abundant in the essential oil 
used in this study, thus the weaker activity of Maxia’s study might be explained.  
Previous studies have shown that  C. albicans is susceptible to oils distilled from carrot 
fruits as well as supercritical carbon dioxide extract (MIC of 640 µg/mL); oils obtained from 
herb, blooming and mature umbels demonstrate  a MIC in the range of 4 and 5 µL/mL (Glisic 
et al., 2007; Staniszewska et al., 2005).  
Essential oils isolated from flowering and mature umbels of other subspecies of Daucus 
carota from Portugal, namely D. carota subsp. halophilus, and D. carota subsp. gummifer have 
both been evaluated against yeasts (Cryptococcus and Candida strains), dermatophytes 
(Trichophyton, Microsporum and Epidermophyton strains) as well as Aspergillus spp. (Maxia et al., 
2009; Tavares et al., 2008; Valente et al., 2015). These studies demonstrated a similar pattern 
on inhibition as shown in this work, with dermatophytes and Ceryptococcus neoformans being 
the most susceptible to the action of D.carota essential oil. 
 Previously the antifungal activity of the major compounds of D. carota subsp. carota oil 
(geranyl acetate, α-pinene and limonene) was assessed. Geranyl acetate was able to inhibit the 
growth of two Aspergillus strains (A. flavus and A. fumigatus) using the well diffusion method 
(Kakarla et al., 2009) whereas using the macrodilution method, this compound demonstrated 
good antifungal effects against dermatophytes and Cryptococcus neoformans, however it had a 
weak performance in inhibiting the growth of Candida strains and Aspergillus spp. (Gonçalves 
et al., 2012; Pinto et al., 2013). Similarly, α-pinene showed  inhibitory effects activity against C. 
albicans and Cryptococcus neoformans (Matsuzaki et al., 2013; Rivas da Silva et al., 2012). 
Moreover, Pinto and colleagues (Pinto et al., 2013) demonstrated that this compound exhibits 
a strong fungistatic and fungicidal activity, being this effect preeminent for Candida and 
Aspergillus spp.. Several authors have also described the antifungal activity of limonene against 
several fungi strains (Chee et al., 2009; Marei et al., 2012; Pinto et al., 2013; Singh et al., 2010; 
Soković et al., 2009; Ünal et al., 2012). Therefore the activity of these major compounds of D. 
carota subsp. carota essential oil may explain the fungistatic and fungicidal activity of this oil. 
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The difference observed between the essential oil and the isolated compounds may be due to 
the presence of minor compounds that might work synergistically or antagonistically with 
these major compounds. 
3.3.1.2. Mechanism of action 
 
.3.1.2.1 Inhbition of germ tube formation in Candida albicans 
The effect of sub-inhibitory concentrations of the essential oil of D. carota subsp. carota 
essential oil on the inhibition of C. albicans germ tube formation is summarized in table 6. The 
essential oil was able to achieve more than 50% inhibition at concentrations as low as 0.04 
µL/mL (MIC/128).  
Table 6. Influence of sub-inhibitory concentrations of the essential oil of Daucus carota subsp. carota on 
germ tube formation of C. albicans ATCC 10231.  
 C. albicans ATCC 10231 
(% of filamentous cells) 
Controla 100 
MIC 
(Conc.b) 
0 
(5) 
MIC/2 
(Conc.b) 
0.59 ± 1.0 
(2.5) 
MIC/4 
(Conc.b) 
0.88 ± 1.54 
 (1.25) 
MIC/8 
(Conc.b) 
1.63 ± 2.82 
(0.64) 
MIC/16 
(Conc.b) 
2.52 ± 4.36 
(0.32) 
MIC/32 
(Conc.b) 
2.90 ± 1.25 
(0.16) 
MIC/64 
(Conc.b) 
21.49 ± 10.89 
(0.08) 
MIC/128 
(Conc.b) 
44.44 ± 8.60 
(0.04) 
MIC/256 
(Conc.b) 
68.54 ± 5.09 
(0.02) 
a Samples with 1% (v/v) DMSO. 
b Concentration in µL/mL. 
3.3.1.2.2 Effect of Candida albicans biofilm 
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Figures 12 and 13 show the effect of the essential oil on preformed C. albicans biofilm. 
It can be observed that all the tested concentrations were able to reduce biofilm biomass and 
viability. The crystal violet method quantifies the biomass of the biofilm by staining it with the 
dye whereas the XTT assay evaluates cell viability by analysing the formation of a water soluble 
crystal whose formation occurs after mitochondrial metabolization. Results show that all the 
tested concentrationsof the essential oil (10-1.25 µL/mL) significantly reduced the biomass of 
the biofilm with p-value of 0.0001 and 0.001 for concentrations of 10-2.5 and 1.25 µL/mL, 
respectively. At the maximum concentration tested (10 µL/mL) the biomass was 52.41% of 
that of the control. Conversely, at the lowest concentration tested the biomass was 77.04% 
of that of the control. The XTT results were in accordance with those observed in the crystal 
violet assay. However, the differences were less significantly when compared to crystal violet 
assay, p-values of 0.05, 0.01 and 0.001 for 2.5, 5 and 10 µL/mL, respectively. At 10 µL/mL the 
cell survival was 68.98% of that of the control whereas at the lowest concentration (1.25 
µL/mL) cell survival was of 91.27% which wasn’t considered statistically significant. 
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Figure 12. Biofilm biomass after treatment with essential oil using the crystal violet assay. Biofilm biomass was 
determined using the formula (Abs620sample/Abs620control)*100. Results are shown as mean ± standard deviation of at least 
three independent determinations carried out in duplicate. ***p<0.001, ****p<0.0001, compared to control using One-way 
ANOVA followed by a Dunnett’s multiple comparison test. 
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Figure 13. Biofilm viability after treatment with essential oil using the XTT viability assay. Biofilm viability was 
determined using the formula (Abs490sample/Abs490control)*100. Results are shown as mean ± standard deviation of at least 
three independent determinations carried out in duplicate. ***p<0.001, ****p<0.0001, compared to control using one-way 
ANOVA followed by a Dunnett’s multiple comparison test). 
 
  As far as it is known, studies on the mechanism of action of D. carota subsp. 
carota essential oil or its isolated major compounds are inexistent. Therefore, the present 
study is the first on the mechanism of action of Daucus carota subsp. carota oil 
In fact, studies regarding the effect of the essential oil of Daucus spp. on germ tube 
formation and biofilm disruption are unknown, however some authors have described those 
effects on other Apiaceae, namely Coriandrum sativum (Bersan et al., 2014; Freires et al., 2014), 
Carum copticum (Khan et al., 2014) and Ferulago capillaris (Pinto et al., 2013). 
When compared to previous studies reporting the antifungal activity of Daucus carota 
subspecies, the present study in addition to the antifungal activity also points out a potential 
mechanism of action to explain the antifungal activity of the oil. Of noteworthy attention is 
the effect of the essential oil on the inhibition of germ tube formation and disruption of 
preformed biofilms in C. albicans. It is known that both the dimorphic transition (yeast to 
filamentous form) and biofilm formation are virulence factors for C. albicans (Mayer et al., 2013; 
Mitchell, 1998). The essential oil demonstrated a strong inhibitory effect on the inhibition of 
the germ tube formation at concentrations thirty-two times lower than MIC (about 97% 
inhibition) which demonstrate potential to be used in the treatment of candidosis nevertheless 
concentrations as low as one hundred and twenty eight times below (MIC/128) were able to 
inhibit the filamentous cells formation by more than 50% (55.56%). The effect of the oil on the 
preformed biofilm was also interesting since a decrease in both biofilm biomass and viability 
V | Bioactive activities and cytotoxicity of Daucus carota subsp. carota essential oil and 
phenolic-enriched extracts 
3. Antifungal activity 
66 
 
was observed at concentrations twice lower than the MIC (2.5 µL/mL, biomass of 64.41% and 
viability of 80.24% when compared to control), thus making it a useful treatment of medical 
devices with C. albicans biofilm. Therefore, essential oil from D. carota subsp. carota is a 
promising natural product to be used as an antifungal agent against these fungi that are 
pathogenic to humans.   
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3.3.2. 70% Methanol Extract 
3.3.2.1. Antifungal activity 
The antifungal activity (MIC and MLC) of the methanolic extract against yeasts, 
dermatophytes and Aspergillus strains is summarized in table 5. The extract was ineffective 
against all tested Candida strains, yet was able to inhibit the growth of Cryptococcus neoformans 
with a MIC of 5 mg/mL and a MLC > 10 mg/mL. Regarding the activity against dermatophytes, 
the extract was able to inhibit the growth of all tested strains (MIC = 1.25-10 mg/mL and MLC 
= 2.5 – 10 mg/mL) excluding Trichophyton verrucosum. All the tested concentrations had no 
effect on the growth of Aspergillus strains.  
Previously, the antifungal activity of the major compounds present in the 
hydromethanolic extract was assessed by several authors. Bajko and colleagues (Bajko et al., 
2015) reported a MIC =10 mg/mL for 5-caffeoylquinic acid against C. albicans. In another study 
the MIC of 3-/4- and 5-caffeoylquinic acid was described as ranging from 0.1 to 0.2 mg/mL for 
C. albicans and A. niger (Xia et al., 2011). The flavonoid rutin was also described as fungistatic 
for two Candida strains, namely C. albicans (MIC=16 mg/mL) and C. krusei (MIC=32 mg/mL) 
(Orhan et al., 2010). Analysing the activity of the major isolated compounds it would be 
expected that the activity of the extract itself would be weaker, however the MIC values were 
lower than the ones described for the major compounds. This variation might be explained by 
the synergetic effect between phenolic compounds found in the whole extract.  
Due to the weak antifungal activity of the phenolic-enriched extracts against C. 
albicans,the germ tube inhibition assay as well as the effect on the biofilm were not performed. 
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4. Antioxidant activity 
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4.1. Introduction 
In aerobic cells, mitochondria are the main site for the generation of reactive oxygen 
species (ROS) since univalent reduction of triplet-state molecular oxygen yields superoxide 
anion (O2˙-). ROS can also be produced by other enzymes such as xanthine oxidase and 
NADPH-oxidases. Although superoxide anion itself has a low reactivity, this species can be 
easily converted via enzymatic or non-enzymatic reactions into highly reactive species (e.g. 
hydroxyl radical and peroxynitrite radical) (Catarino et al., 2015).   
In order to maintain the redox homeostasis, cells have several mechanisms that control 
the balance between ROS and reactive nitrogen species (RNS) generation and elimination. 
This control is achieved by the action of both enzymatic and non-enzymatic antioxidant agents. 
For instance, superoxide anion is converted into oxygen and hydrogen peroxide by superoxide 
dismutase and the latter is further converted into water and oxygen by the enzyme catalase. 
Food is a source of dietary/non-enzymatic antioxidants such as polyphenols, vitamin C and E, 
as well as carotenoids (Catarino et al., 2015; Huang et al., 2005).  
These systems can, however, be disrupted in some cases, such as smoking and  UV 
exposure (Catarino et al., 2015; Rahimuddin et al., 2007). In these conditions the cells enter 
an oxidative stress state which triggers signalling cascades and induces the production of 
reactive species that enter in a vicious cycle as the overproduction of one species increases 
the production of another species (Catarino et al., 2015). As result, these ROS and RNS will 
react with macromolecules (e.g. DNA, lipids, proteins) leading to several pathogenic 
conditions (Catarino et al., 2015) such as Alzheimer’s disease, Parkinson’s disease, 
atheroscleorosis, cancer, arthritis, immunological incompetence and other neurodegenerative 
disorders (Badarinath et al., 2010; Rahimuddin et al., 2007; Yu et al., 2005) 
Antioxidant agents may perform both a direct or indirect effect. Direct effects are 
measured by their ability to scavenge free radicals, to quench ROS, to chelate metal ions and 
to inhibit lipid peroxidation (Catarino et al., 2015; Tongnuanchan et al., 2014). Conversely, 
indirect effects are mainly due to modulation of key antioxidant enzymes or interaction with 
receptors important to signalling pathways (Catarino et al., 2015). The radical scavenging action 
of antioxidant agents are explained mainly by two mechanisms, namely Hydrogen Atom 
Transfer (HAT) and Single Electron Transfer (SET) (Catarino et al., 2015; Karadag et al., 2009). 
In HAT reactions, the hydrogen from the compounds passes to the radical resulting in the 
formation of a non-reactive compound. On the other hand, SET is explained by the 
V | Bioactive activities and cytotoxicity of Daucus carota subsp. carota essential oil and 
phenolic-enriched extracts 
5. Anti-inflammatory activity 
71 
 
transference of an electron between the antioxidant agent and the radical causing its reduction 
(Catarino et al., 2015). The most generalist HAT-based methods for the evaluation of 
antioxidant capacity are based upon an oxidizable molecular probe in the presence of a free 
radical generator and the antioxidant agent (Karadag et al., 2009). Oxygen radical absorbance 
capacity (ORAC) and trapping antioxidant parameter (TRAP) are commonly used in HAT-
based antioxidant methods that measure the capability to inhibit peroxyl radical-induced 
oxidations. Conversely, in SET-based methods only an antioxidant and a probe is present as 
in these methods the probe is the oxidant agent that will substract an electron from the agent 
causing a colour shift (Huang et al., 2005; Karadag et al., 2009). Trolox equivalent antioxidant 
capacity (TEAC), 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) scavenging assay and ferric ion 
reducing antioxidant power (FRAP) are examples of SET-based methods. 
The antioxidant ability of D. carota essential oils and extracts has been assessed in 
chemical models, namely using the DPPH● (2,2’-diphenyl-1-picrylhydrazyl) scavenging assay 
and ABTS●+ (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)) decolourization assay, 
metal chelating power and oxygen radical absorbing capacity (ORAC) (Guinoiseau et al., 2010). 
Overall, the antioxidant potential of the samples was attributed to the presence of both 
nutritional (e.g. vitamins A, C and E) and non-nutritional (e.g. phenolic compounds, 
carotenoids) antioxidants (Guinoiseau et al., 2010). 
 
4.2. Material and Methods 
  
4.2.1. Essential oil and phenolic-enriched extracts 
 The essential oil and the phenolic-enriched extracts (MeOH 70%, MeOH 100% and 
H2O) were obtained as described before in section 1 of chapter V. 
4.2.2. Reagents 
 Gallic acid, ABTS-[NH4]2 ([2,2’-azinobis(3-ethylbenzothiazoline-6- sulfonic acid] 
diammonium salt), the standard Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic 
acid) and Folin-Ciocalteu reagent were purchased from Sigma Chemical Co. (St. Louis, MO, 
USA). Sodium dihydrogen phosphate anhydrous was obtained from Panreac (Barcelona, Spain). 
AAPH (2,2’-azobis(2-amidino-propane) dihydrochloride) and fluorescein were from Acros 
Organics (Geel, Belgium).  
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4.2.3. Folin-Ciocalteu reagent based assay 
 
 Folin-Ciocalteu reagent (FCR) based assay is a SET-based method as an electron is 
transfered between the compound and molybdenum (Karadag et al., 2009). This method can 
be considered an antioxidant assay as it de facto measures the reducing power of the sample 
(Huang et al., 2005). However, it is more promptly used for the determination of the phenolic 
content in the samples. Due to this, it is rarely used in essential oils since they are rich in 
terpenes and terpenoids and not in polyphenols as verified in other extracts. FCR is a widely 
used method as it is easy, cheap and very reproducible.  In addition, a very strong correlation 
between FCR and other antioxidant assays (e.g. DPPH, TEAC, FRAP) is found (Huang et al., 
2005; Karadag et al., 2009). However this method has some drawbacks, namely lack of 
standardization as the reaction is dependent on the reactivity of the standard compound, i.e. 
the more hydroxyl moieties the higher the absorbance. Another drawback is that although it 
measures total phenolic content, the reaction can also occur in the presence of non-phenolic 
compounds, thus leading to erroneous conclusions (Karadag et al., 2009). 
The total phenolic content of the phenolic-enriched extracts was determined using the 
method described by Singleton and Rossi (Singleton et al., 1965) with some modifications. 
Briefly, to 100µL of extract solution (1 mg/mL), 1500µL of distilled water and 100µL of Folin 
Ciocalteu reagent were added. Following a 2 min incubation, 300µL of sodium carbonate 17% 
(w/v) was added to the test tubes and mixed in a vortex agitator and the reaction was carried 
out on a water bath at 40ºC for 30 min. The sample absorbance was read at 765 nm on a 
spectrophotometer against a negative control, which was made by using 100µL of distilled 
water instead of the sample. The total phenolic content was determined using a standard curve 
made with gallic acid (20-200 µg/mL) and the results were expressed as µg of gallic acid 
equivalent per milligram of dried extract (µg GAE/mg DE). Results are presented as mean 
values ± standard deviation of three independent assays. All determinations were performed 
in duplicate. 
4.2.4. Antioxidant properties  
 
4.2.4.1. ABTS radical cation assay 
This method, also known as Trolox equivalent antioxidant capacity (TEAC), measures 
the capacity of the compound to reduce the absorbance of an intensely coloured solution of 
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2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonate) (ABTS˙+) (Karadag et al., 2009; Wood et al., 
2006). The ABTS is a peroxidase substrate and can also be chemically oxidised into the radical 
in the presence of peroxyl radicals that can be formed in the presence of potassium persulfate 
(Karadag et al., 2009). This method is a rather simple method thus making it widely used for 
the determination of antioxidant capacity (Huang et al., 2005; Wood et al., 2006). In addition 
the ABTS salt can be solubilized in either aqueous or organic solvents allowing the evaluation 
of both lipophilic and hydrophilic antioxidants (Huang et al., 2005; Karadag et al., 2009). 
Nevertheless this method has some limitations, namely it evaluates the capacity to react with 
the radical instead of the inhibition of the oxidative process. Also, the TEAC values can be 
false as some compounds take long periods of time to achieve the end-point. Moreover, the 
ABTS radical is a synthetic compound not found in biological systems (Karadag et al., 2009). In 
this assay the reduction of the radical is achieved by either electron or H atom transfer (Wood 
et al., 2006),  
ABTS˙+ decolourization assay was performed as described by Re et al. (Re et al., 1999). 
The ABTS˙+ stock solution was generated by reacting 7 mM (ABTS-[NH4]2) with 2.45 mM di-
potassium persulfate (K2S2O8) in the dark at room temperature for 12-16h. The working 
solution was prepared daily by diluting the stock solution with absolute ethanol until an 
absorbance of 0.700±0.03. 1mL of ABTS˙+ was added to 10µL (for MeOH 70% and MeOH 
100%) or to 30µL (H2O) of 1mg/mL extract solutions, or to 100µL of 20mg/mL of an essential 
oil solution made in DMSO. Exactly after 20 min, the absorbance was read at 734 nm in a 
spectrophotometer against a blank (absolute ethanol). The antioxidant power of samples was 
expressed as IC50 (µg/mL). All determinations were made in duplicates. Data are shown as 
mean values ± standard deviation of three independent assays.  
4.2.4.3. Oxygen radical antioxidant capacity assay 
Oxygen radical antioxidant capacity (ORAC) evaluates the capacity of the antioxidant 
agent to inhibit peroxyl radical-induced oxidations and is based upon H-atom donation for 
chain breaking (Huang et al., 2005; Karadag et al., 2009; Wood et al., 2006). This methods is 
preferable as peroxyl radicals are the most common free radicals found in biological systems 
(Wood et al., 2006). This is a fluorescent method in which the antioxidant agent is incubated 
with fluorescein (a fluorescent probe) at 37 ºC and then AAPH (a peroxyl radical generator) 
is added and the fluorescence is measured for 60 min (Karadag et al., 2009). The decrease in 
the fluorescence is a signal of oxidative damage by the action of peroxyl radicals (Karadag et 
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al., 2009). In the presence of an antioxidant agent this decay is delayed (Karadag et al., 2009). 
ORAC is advisable for antioxidant compounds that have no lag phase. Also, different free 
radical generators can be used, e.g. AAPH as peroxyl generator or Cu2+-H2O2 as a hydroxyl 
generator (Karadag et al., 2009). However, the original method is only able to evaluate the 
antioxidant capacity of hydrophilic agents, whereas to detect lipophilic agents several 
modifications to the original methods must be made, e.g. using a solubility enhancer and a lipid 
soluble radical generator (Huang et al., 2005; Karadag et al., 2009) 
Oxygen radical antioxidant capacity (ORAC) was determined using the method 
described by Garret et al. (Garrett et al., 2010) with some modifications. Briefly, a working 
solution of fluorescein 10 nM was made by diluting a stock solution of 100 µM in phosphate 
buffer (75 mM, pH 7.4) and a Trolox solution (200-25 µM) was made by diluting a stock 
solution of 1 mM in phosphate buffer. 150µL of fluorescein was pipetted to a 96-ewell plate 
and 25 µL of Trolox or sample (0.5 – 0.01 mg/mL for extracts and 10 – 0.32 mg/mL for 
essential oil) was added. For negative and positive controls, 25 µL of phosphate buffer was 
used. This mixture was incubated at 37ºC for 10 min for temperature stabilization as AAPH-
dependent peroxyl radical formation is optimal at this temperature. After that, 25 µL of AAPH 
(153 mM) was added to all wells except that of negative control that contained 25 µL of 
phosphate buffer. The fluorescence was immediatly read on a plate reader every 1 minute with 
5 seconds shaking prior to each reading, in a total of 60 min. The emission wavelength was set 
at 530/20 nm and excitation wavelength at 485/20 nm. Area under the curve (AUC) was 
determined by the following equation (1) 
 
Where A0 is the fluorescence at t=0 min and Ai is the fluorescence at t=i. Results are 
expressed as Trolox Equivalent (TE)/mg DW of each sample range which is determined by the 
equation (2) where mSample is the slope of the linear regression analysis of the sample and 
mTrolox is the slope of the linear regression analysis of Trolox: 
 
Results are shown as mean ± S.E.M of at least three independent experiments. All 
determinations were made in duplicate. 
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4.2.5. Statistical analysis 
 The statistical analysis comparing the control group with the different treatment groups 
was performed using an ordinary one-way ANOVA with Dunnett’s multiple comparison test 
with significance levels *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. These tests were 
conducted in GraphPad Prism version 6 (GraphPad Software, San Diego, CA, USA). 
4.3. Results and Discussion 
 
4.3.1. Folin-Ciocalteu reagent based assay  
The total phenolic content (TPC) of the extracts was determined using the Folin-
Ciocalteu method. The results showed that TPC content was very similar in all three samples 
showing no statistical differences between them. The TPC of aqueous extract was 118.1 ± 9.7 
µg GAE/mg DW while (hydro)methanolic extracts had a very similar TPC value i.e. 134.2 
±10.3 and 134.6 ± 1.9 µg GAE/mg DW for MeOH 70% and MeOH 100%, respectively (Figure 
14).  
 
Figure 14 - Total phenolic content (TPC) of phenolic-enriched extracts. Results are shown as mean ± S.E.M of 
three independent determinations made in duplicate. 
 
To the author´s knowledge, there are no studies regarding the total phenolic content 
of the aerial parts of carrot, being the reported data limited to carrot roots. Leja et al. (Leja 
et al., 2013) assessed the TPC in hydroacetone extracts from roots of white, yellow, orange, 
red and purple carrots and the values were 18, 21.5, 29.3, 31 and 245.7 µg GAE/100 mg FW. 
Algarra and colleagues (Algarra et al., 2014) described that TPC was 9.4, 187.8 and 492.0 µg 
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GAE/100 mg FW for 50% ethanol extracts obtained from orange, black and purple carrots, 
respectively. Koley and colleagues (Koley et al., 2014) tested several 80% acetone extracts 
from Indian cultivars with red, orange and purple carrots and TPC values ranged from 6.41 to 
290.3 µg/100 mg FW. TPC of 80% ethanol carrot root extracts varied from 21 to 87 mg 
GAE/100 g FW (Singh et al., 2012).  Since these values were expressed as µg GAE/100 mg FW 
and the herein obtained are presented in µg GAE/mg DW, a direct comparison between them 
is not possible. 
4.3.2. ABTS˙+ scavenging ability  
 Figure 15 show the ABTS˙+ scavenging capacity of the tested samples expressed as IC50. 
Among them, the essential oil had the weakest activity (IC50=1924 ± 124.2 µg/mL. Conversely, 
the phenolic-enriched extracts had much better activity, being the aqueous extract the 
weakest amongst them (IC50=142.2 ± 23.4 µg/mL). Again, both methanolic extracts have a 
very similar activity, IC50= 44.6 ± 3.2 and 42.54 ± 1.7 µg/mL for 70% and 100% methanol 
extracts, respectively. 
Up to date, no studies of TEAC using extracts or essential oils from aerial parts of D. 
carota have been described, with investigations focusing primarily on carrot roots. Koley and 
colleagues (Koley et al., 2014) analysed several red, orange and purple carrot cultivar extracts 
and demonstrated that the TEAC of those samples ranged between 1.63 and 57.53 µmol 
Trolox/g FW. In another study, 80% methanol extracts of carrot roots showed a TEAC ranging 
from 0.170 to 1.480 mmol TE/100 g DW (Morales-Soto et al., 2014). Yu and colleagues (Yu et 
al., 2005) obtained a methanol extract of carrot seed oil which had an activity of 8.90 µmol 
TE/g oil and TEAC of 80% acetone extracts of red, purple and orange carrot roots ranged 
from 1.63 to 57.53 µmol TE/g FW (Koley et al., 2014). 
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Figure 15 - Trolox Equivalent Antioxidant Capacity (TEAC) of the essential oil and phenolic-enriched 
extracts using ABTS cation radical scavenging assay. Results are shown as mean ± S.E.M of at least three 
independent assays, done in duplicate. Statistically significant differences when compared to Trolox (*p<0.05, ****p<0.001, 
using one-way ANOVA followed by Dunnett’s multiple comparision test). 
 
 Moreover, studies evaluating the antioxidant potential through ABTS and DPPH of the 
major compounds of D. carota subsp. carota essential oil (geranyl acetate, α-pinene, 11αH-
himachal-4-ene-1-β-ol and limonene) are absent and hence, any hypothetical contribution of 
these compounds for the activity of the sample cannot be inferred. However, studies using 
some major compounds of the extracts are available. In fact, Yuan and colleagues (Yuan et al., 
2012) evaluated the IC50 using the ABTS˙+ scavenging assay of several caffeyolquinic and 
dicaffeoylquinic acids and the values were in the range of 2.79 and 6.27 µM. The IC50 of 1,3-
dicaffeoylquinic acid was 12 µM in the ABTS˙+ scavenging assay (Danino et al., 2009). Rutin, a 
major flavonoid in the extracts, had an IC50 of 5.65 µg/mL in the DPPH assay, although this 
test was not performed in this study, it serves to elucidate that rutin is able to scavenge radicals 
via single-electron transfer. These studies are elucidative about the activity of the whole 
extracts. The differences observed are explained by the presence of synergic or antagonistic 
minor compounds in the extracts. 
 
4.3.3. Oxygen Radical Antioxidant Capacity (ORAC) assay 
Figure 16 shows the ORAC of the different tested samples expressed in TE (Trolox 
equivalents)/mg DW. Similarly to what has been described for the ABTS˙+ scavenging assay, 
the essential oil had the weakest performance with an activity of 7.13 ± 1.5 µmol TE/mg oil. 
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The MeOH 100% and H2O extracts had a similar activity, 4.3 ± 1.1 and 4.5 ± 1.1 µmol TE/g 
DW, respectively. The extract made with 70% methanol had a slightly weaker activity however 
still stronger than the essential oil, 3.1 ± 0.7µmol TE/g DW.  
 
Figure 16 - Oxygen Radical Scavenging Capacity (ORAC) of the essential oil and phenolic-enriched extracts. 
TE was determined by the ratio of the slope of the linear regression of each sample with that of a Trolox standard curve. 
Results are shown as mean ± S.E.M of at least three independent assays done in duplicate. Significant differences compared 
to standard compound, Trolox (**p<0.01, ***p<0.001, using a one-way ANOVA followed by a Dunnett’s multiple 
comparision test) 
 
 In previous assays, a methanol extract of carrot seed oil had an ORAC activity of 160 
µmol TE/g oil (Yu et al., 2005) wheareas a 80% ethanol extract had and ORAC activity ranging 
from 0.48 to 1.17 mmol Trolox/100 g FW (Singh et al., 2012).  
 The flavonoid rutin was also tested for its ORAC and showed an IC50 of 12.041 mmol 
TE/g DW (Wang et al., 2013). Although the activity of this phenolic compound is higher than 
the ones described by the studied extracts, the amount of rutin in our extracts is rather low 
thus the activity is not as preeminent as the isolated compound. In addition, the presence of 
minor phenolic compounds with antagonistic effect on rutin might also occur.  
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5.1. Introduction 
The inflammation is a pathophysiological response of living tissue to either a parasitic 
invasion or an injury/trauma, as well as other hostile conditions not related to host defence 
or tissue repair in order to restore body homeostasis (Ashley et al., 2012; Medzhitov, 2008; 
Vasudevan et al., 2006). During this process an increase in the permeability of endothelial cells 
is verified, leukocytes migrate to the interstitium, an oxidative burst occurs and cytokines both 
pro- and anti-inflammatory are released. In addition, several enzymes are induced which leads 
to the metabolization of arachidonic acid into eicosanoids, prostaglandins (PGs) and 
thromboxane A2. Likewise, the expression of adhesion molecules, namely intracellular 
adhesion molecules (ICAM) and vascular cell adhesion molecules (VCAM) is also increased 
(Miguel, 2010). 
Key players in the immune response are the activated macrophages, which are 
responsible for the production of numerous pro-inflammatory mediators, namely pro-
inflammatory cytokines, nitric oxide (NO), PGs, and Reactive Oxygen Species (ROS) 
(Medzhitov, 2008). NO synthase is responsible for the formation of NO from L-arginine and 
molecular oxygen, while cyclooxygenase catalyses the production of PGs via the arachidonic 
acid pathway. These enzymes have inducible forms, iNOS and COX-2, respectively, which are 
activated by several inflammatory stimuli (e.g. LPS, cytokines, and nitric oxide). Their pathways 
are closely related and NO can stimulate COX-2 activity via interaction with the heme 
component (Dudhgaonkar et al., 2004). It is known that the presence of high amounts of NO 
is an inflammation marker. Hence, in this context, the capacity to inhibit its production can be 
used to track new anti-inflammatory agents. 
The expression of pro-inflammatory mediators is regulated by various transcription 
factors and signalling pathways. One transcriptional factor that regulates the expression of 
several genes is nuclear transcription factor kappa B (NF-κB), which is found in its inactivated 
state due to the presence of IκB inhibitor protein (seven members containing IκBα). Upon 
pro-inflammatory stimuli phosphorylation of IκBα occurs, causing NF-κB to be released and 
to be translocated to nucleus where it regulates gene transcription by binding to target genes. 
The binding of NF-κB to nuclear DNA leads to the expression of several genes that 
concomitantly induce the expression of pro-inflammatory cytokines, e.g. interleukine-1β and 
Tumor Necrosis Factor α (TNF-α), chemokines and other co-stimulatory molecules (Ashley 
et al., 2012; Scheidereit, 2006; Wong et al., 2009).  
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Impaired inflammatory responses are implicated in several chronic diseases such as 
cancer (Khatami, 2012; Porta et al., 2009), obesity, diabesity (Schmidt et al., 2003), rheumatoid 
arthritis, cardiovascular diseases, neurodegenerative diseases (Hunter et al., 2010), 
inflammatory bowel disease (Predonzani, 2015) and aging. Currently, these diseases are a 
major burden despite the recent success in biopharmaceuticals. Absence of responsiveness 
and drug resistance, delivery problems and the cost of biopharmaceutical drugs validate the 
search for new anti-inflammatory agents and the development of new approaches to control 
these diseases. The perfect anti-inflammatory drug would be able to relieve pain and 
inflammation, along with the capacity to slow down, stop or, even better, prevent the disease 
progression (Zuzarte, 2012). 
Traditional medicine has been using plants since immemorial times to alleviate 
inflammatory disorders and has been providing front-line pharmacotherapy for millions of 
individuals worldwide (Recio et al., 2012). Medicinal plants are, therefore, a potential source 
of biologically active molecules, as well as a promising avenue for the discovery of new drugs 
(e.g. aspirin which is derived from salicylic acid from Salix species) (Recio et al., 2012). In fact, 
several lines of investigation are based on the anti-inflammatory activity of essential oils and 
phenolic-enriched extracts and/or their constituents (Zuzarte, 2012). 
Plant-derived pharmacological agents belong to a wide panoply of chemical compounds 
such as flavonoids, terpenoids, quinones, catechins, alkaloids, amongst others, which are 
known to modulate the pro-inflammatory signals (Recio et al., 2012), scavenge free radicals, 
modulate the arachidonic acid metabolism as well as the production of cytokines (Zuzarte, 
2012). 
In what concerns the anti-inflammatory activity of Daucus carota, only a few studies 
have been conducted. Momin and colleagues (Momin et al., 2003) demonstrated that trans-
asarone, 2,4,5-trimethoxybenzaldehyde and oleic acid isolated from Daucus carota seed hexane 
extract were able to inhibit COX activity, being 2,4,5-trimethoxybenzaldehyde specific for 
COX-2. Moreover, the ethanolic extract of carrot seed was able to inhibit carrageenan-, 
histamine- and serotonin-induced paw oedema as well as formaldehyde-induced arthritis. In 
addition, this extract demonstrated analgesic and antinoceptive properties (Vasudevan et al., 
2006). A chromatographic fraction of purple carrot seed methanolic extracts was able to 
reduce NO, pro-inflammatory cytokines and iNOS levels. The authors associated the NO 
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reduction to the presence of polyacetylenes (falcarinol, falcarindiol and falcarindiol-3-acetate) 
in the fraction (Metzger et al., 2008).  
Noteworthy many authors do not identify the subspecies used in their works and this is an 
important aspect to consider taking into account the high intraspecific polymorphism of this 
species, as well as the economic potential of the subspecies carota. Having this problematic in 
mind, the anti-inflammatory activity of the essential oil from Daucus carota subs carota was 
herein assessed for the first time.  
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5.2. Material and methods  
The anti-inflammatory potential of the essential oil was performed using both a 
chemical (NO● cavenging assay using SNAP as a NO donor) and a cellular model (LPS-
stimulated RAW 264.7 macrophages). The anti-inflammatory assay was only considered for 
the essential oil as it was the most promising sample in both antifungal and antibacterial 
properties.  
5.2.1. Essential oil 
 The essential oil used in these assays was the same used in the previous ones. 
5.2.2. Materials  
Reagents were purchased from Sigma Chemical Co. (Saint Louis, MO). Specifically, 
Dulbecco’s Modified Eagle Medium and fetal bovine serum were obtained from Gibco 
(Invitrogen, Paisley, UK). 
5.2.3. Nitric oxide scavenging assay in a chemical model 
NO scavenging assay was performed using a chemical model in accordance with 
previous studies conducted by our team (Valente et al., 2015). Briefly, 6 µL of serial double 
dilutions of essential oil (1.25 – 0.08 µL/mL) was added to 300 µL of DMEM in a 48-well plate. 
Then, 0.9 µL of S-nitroso-N-acetyl-D,L-penicillamine (SNAP, 100mM) was used as a NO donor 
and added to the wells. The plate was incubated at 37ºC for 3h. At the end of reaction time, 
170 µL of supernatant was collected to 96-well plates and 170 µL of Griess Reagent 
(Sulphanilamide 1% (m/v) on H3PO4 5% (m/v), N-(1-naphtyl)-ethyldiamine 0.1% (m/v); 1:1) was 
added and left to stand for 30 min in the dark, at room temperature. The absorbance was 
read at 550 nm on a plate reader without filters, against a negative control (only DMEM) and 
a positive control (DMEM + SNAP). The nitrite concentration was determined from a linear 
regression analysis using serial dilutions of sodium nitrite as standard (50 – 0.000 mM). All 
determinations were made in duplicate. The results are shown as mean ± standard deviation 
of three independent determinations. 
5.2.4. Cell culture 
RAW 264.7, a mouse leukaemic macrophage cell line  (ATCC (TIB-71) was cultured 
in endotoxin-free Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% (v/v) 
non-inactivated foetal bovine serum, 3.02 g/L sodium bicarbonate, 100 µg/mL streptomycin 
and 100 U/mL penicillin at 37ºC, in an humidified atmosphere of 95% air and 5% CO2. The 
cells were used when the confluence was 80-90%. Viable cells were counted on a 
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haemocytometer using Trypan blue dye. Morphological changes was monitored 
microscopically. 
5.2.5. Cell Viability 
To evaluate the cytotoxicity of the oil, the resazurin assay was used according to Riss 
(2013) with slight modifications Macrophages (0.3×106 cells/well) were plated in 48-well 
microplates and allowed to stabilize for 12h. Then, cells were either maintained in culture 
medium (control) or incubated with different concentrations (1.25 – 0.08 µL/mL) of the 
essential oil for 24h. After treatment, the resazurin solution (C=0.125 mg/mL) was added 
(1:10) and cells were incubated at 37ºC for 30 min in a humidified atmosphere of 95% air and 
5% CO2. Quantification was performed using an ELISA microplate reader (SLT, Austria) at 570 
nm, with a reference wavelength of 620 nm. A cell-free control was performed in order to 
exclude non-specific effects of the oils on resazurin (data not shown).  
5.2.6. In vitro anti-inflammatory activity 
To evaluate the anti-inflammatory potential of the oil, macrophages (0.3 x 106 cells 
/well) were cultured in 48-well microplates and allowed to stabilize for 12h. Following this 
period, cells were either maintained in culture medium (control) or pre-incubated with 
different concentrations of the essential oil for 1h, and later activated with LPS (1 µg/mL) for 
24h. The production of NO was evaluated by measuring the accumulation of nitrites in the 
culture supernatants, using the colorimetric Griess reagent (Green et al., 1982). Briefly, an 
aliquot of culture medium was diluted with equal volume of the Griess reagent and maintained 
during 30 min, in the dark. The absorbance was measured using an ELISA microplate reader 
(SLT, Austria) at 550 nm. Culture medium was used as blank and nitrite concentration was 
determined from a linear regression analysis using serial dilutions of sodium nitrite as standard. 
5.2.7. Statistical analysis 
 The statistical analysis comparing the control group with the different treatment groups 
was performed using an ordinary one-way ANOVA with Dunnett’s multiple comparison test. 
These tests were applied using GraphPad Prism version 6 (GraphPad Software, San Diego, 
CA, USA). 
 
5.3. Results and Discussion 
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5.3.1. Nitric oxide scavenging assay using a chemical model 
 The figure 17 shows the nitric oxide scavenging capacity of the essential oil expressed 
in mM of nitrites after the treatment of culture medium with essential oil following the addition 
of the NO donor, SNAP. It can be seen that for the tested concentrations (1.25 – 0.08 µL/mL), 
the essential oil showed no ability to scavenge the NO release triggered by SNAP. 
 
Figure 17 - Nitric oxide scavening of Daucus carota subsp. carota essential oil. Results are shown as mean ± S.E.M 
of three independent assays, done in duplicate. No statistically significant differences were found using a one-way ANOVA 
followed by a Dunnett’s multiple comparison test. 
 
 Up to date, no studies regarding the nitric oxide inhibition capacity of the essential oils 
from Daucus carota subsp. carota have been conducted. However, Valente and colleagues 
(Valente et al., 2015) performed some studies on Daucus carota subsp. gummifer and showed 
that the essential oil from this subspecies had significant NO scavenging activity (about 30% 
NO reduction at 0.08 µL/mL), using the same method. However, the essential oil of D. carota 
subsp. gummifer has a distinct chemical composition from that of Daucus carota subsp. carota, 
reported in this study, being the main compounds in subsp. gummifer trans-β-ocimene (31.3%), 
sabinene (29.0%) and cis-β-ocimene (12.3%). Moreover, the NO scavenging of sabinene was 
previously reported (about 30% NO reduction at 0.64 µL/mL) (Valente et al., 2013), and this 
could partially contribute for the NO scavenging activity of subsp. gummifer. Regarding the 
subsp. carota, sabinene is not a major compound and no studies have been reported for the 
main compounds identified in the oil in the present study (geranyl acetate, α-pinene, 11αH-
himachal-4-ene-1-β-ol and limonene).  
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5.3.2. Nitric oxide scavenging in a cellular model 
 As shown in Figure 18, incubation of macrophages (Fig. 18a) with LPS, for 24h, resulted 
in a significant increase in nitrite production compared to the control (1.29 µM vs 25.21 µM). 
Taking into account the toxicity of the oil presented in Figure 18b and described in the 
following section (6. Cytotoxicity), inhibition of NO production was only considered for non-
toxic concentrations of the oil (i.e. up to 0.64 µL/mL). Therefore, the results obtained show 
that the treatment of LPS-stimulated macrophages with 0.64 µL/mL of D. carota subsp. carota 
essential oil caused a decrease around 19% on the production of NO (Fig. 18a; p<0.05). 
 
Figure 18 - Anti-inflammatory effect of Daucus carota subsp. carota on LPS-stimulated RAW 264.7 
macrophages: a) Nitric oxide production and b) cell viability. The cells were treated with essential oil (1.25 – 0.08 
µL/mL) for 1h prior to LPS (1µg/mL) addition and incubated for another 24h before NO release evaluation and resazurin 
(0.125 mg/mL) was added to assess cell viability. Results are shown as mean ± S.E.M of at least three independent assays. 
Significant difference when compared to LPS-treated cells (*p<0.05; **p<0.01; ***p<0.0001 using one-way Anova followed 
by Dunnett’s multiple comparison test). 
 
Studies regarding the anti-inflammatory properties of D. carota essential oil are very 
scarce. Some authors have demonstrated the anti-inflammatory potential of other Apiaceae 
namely Oenanthe crocata (Valente et al., 2013), Distichoselinum tenuifolium (Tavares et al., 2010) 
and Anethum graveolens (Kazemi, 2014). Moreover, the anti-inflammatory potential of D. carota 
subsp. gummifer essential oil was also evaluated using the same inflammation model (Valente 
et al., 2015). This subspecies oil was also able to reduce NO production at 0.64 µL/mL although 
a higher inhibition was achieved (65.15%). This difference is probably explained by the different 
chemical composition of both oils, since  D. carota subsp. gummifer is enriched in trans-β-
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ocimene, sabinene and cis-β-ocimene which are known to be anti-inflammatory (Valente et al., 
2013).  
The anti-inflammatory properties of some major compounds identified in the present 
study in the oil of D. carota subsp. carota have also been described. Rufino and colleagues 
assessed the anti-inflammatory properties of both α-pinene (68.5% of NO inhibition at 200 
µg/mL) and limonene (IC50 of 85.3 µg/mL) (Rufino et al., 2014, 2015). Kazemi (Kazemi, 2014) 
also evaluated the anti-inflammatory effect of limonene (45 µM reduces the NO production 
to 70.87%). Moreover, geranyl acetate is able to reduce the NO production from 125% (LPS-
treated cells) to 100% at 0.64-0.32 µg/mL without showing toxicity (Gonçalves et al., 2012). 
The activity of these major compounds might partially explain the activity of the D. carota 
subsp. carota essential oil although minor compounds may have an antagonistic effect, thus 
slightly reducing the antin-inflammatory effect 
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5.3.2. Nitric oxide scavenging in a cellular model 
 As shown in Figure 18, incubation of macrophages (Fig. 18a) with LPS, for 24h, resulted 
in a significant increase in nitrite production compared to the control (1.29 µM vs 25.21 µM). 
Taking into account the toxicity of the oil presented in Figure 15b and that described in the 
following section, inhibition of NO production was only considered for non-toxic 
concentrations of the oil (i.e. up to 0.64 µL/mL). Therefore, the overall obtained results 
allowed to conclude that the treatment of LPS-stimulated macrophages with the essential oil 
of D. carota subsp. carota caused a decrease on the NO production,  by about 19% (Fig. 15a; 
p<0.05). 
 
Figure 19 - Anti-inflammatory effect of Daucus carota subsp. carota on LPS-stimulated RAW 264.7 
macrophages: a) Nitric oxide production and b) cell viability. The cells were treated with essential oil (1.25 – 0.08 
µL/mL) for 1h prior to LPS (1µg/mL) addition and incubated for another 24h before NO release evaluation and resazurin 
(0.125 mg/mL) was added to assess cell viability. Results are shown as mean ± S.E.M of at least three independent assays. 
Significant difference when compared to LPS-treated cells (*p<0.05; **p<0.01; ***p<0.001 using one-way Anova followed by 
Dunnett’s multiple comparison test). 
 
Studies regarding the anti-inflammatory properties of D. carota essential oil are very 
scarce. Some authors have demonstrated the anti-inflammatory potential of other Apiaceae 
genus, namely Oenanthe crocata (Valente et al., 2013), Distichoselinum tenuifolium (Tavares et al., 
2010) and Anethum graveolens (Kazemi, 2014). Moreover, the anti-inflammatory potential of D. 
carota subsp. gummifer essential oil was also evaluated using the same inflammation model 
(Valente et al., 2015). This subspecies oil was also able to reduce NO production at 0.64 µL/mL 
although a higher inhibition was achieved (65.15%). This difference is probably explained by 
the different chemical composition of both oils, since  D. carota subsp. gummifer is enriched in 
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trans-β-ocimene, sabinene and cis-β-ocimene which are know to be anti-inflammatory (Valente 
et al., 2013).  
The anti-inflammatory properties of some major compounds identified in the present 
study in the oil of D. carota subsp. carota have also been described. Rufino and colleagues 
assessed the anti-inflammatory properties of both α-pinene (68.5% of NO inhibition at 200 
µg/mL) (Rufino, Ana T. et al. 2014) and limonene (IC50 of 85.3 µg/mL) (Rufino et al., 2015). 
Kazemi (Kazemi, 2014) also evaluated the anti-inflammatory effect of limonene (45 µM reduces 
the NO production to 70.87%). Moreover, geranyl acetate is able to reduce the NO 
production from 125% (LPS-treated cells) to 100% at 0.64-0.32 µg/mL without showing 
toxicity (Gonçalves et al., 2012). The activity of these major compounds of the essential oil 
might partially explain the activity of the D. carota subsp. carota EO per se, although the activity 
is weaker. This difference is explained by the presence of minor compounds that don’t have 
any activity or have an antagonistic effect. 
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6. Cytotoxicity  
 
  
V | Bioactive activities and cytotoxicity of Daucus carota subsp. carota essential oil and 
phenolic-enriched extracts 
6. Citotoxicity 
93 
 
V | Bioactive activities and cytotoxicity of Daucus carota subsp. carota essential oil and 
phenolic-enriched extracts 
6. Citotoxicity 
94 
 
6.1. Introduction  
 Although medicinal and aromatic plants are long used in traditional medicine, many 
usages are based upon anecdotal evidence instead of scientific research thus the need to 
implement thoughtful and well-designated studies in order to avoid misleading reports as well 
as to elucidate their efficacy and safety. In addition to animal as well as clinical evidences, safety 
assays must also be considered. Lately, in vitro toxicity assays have been developed with the 
aim to substitute animal testing methods in early phases of drug development (Bhanushali et 
al., 2010). 
The usage of natural products in the food and health industry as a source of bioactive 
compounds has become more and more popular, in addition to their recognized usage in 
cosmetic and perfumery industries (Lahlou, 2004). Currently in aromatherapy, aromatic plants 
and their essential oils are greatly used due to their effect on the central nervous system, 
namely mood, anxiety and depression improvement (Edris, 2007). The application of essential 
oils is normally achieved via inhalation, topical application or oral administration (Reichling et 
al., 2009). The evaluation of the sensitization, carcinogenicity and toxicity of essential oils is 
constantly carried out by several associations/programs, such as Research Institute for 
Fragrance Materials (RIFM), International Flavour and Fragrance Association (IFRA), Flavour 
Essence Manufacturers Association (FEMA) and National Toxicology Program (NTP) with the 
purpose of establishing their No Adverse Effect Level (NOAEL) (Vigan, 2010).  
Toxicity assays are generally assessed to determine the cytotoxic effect of the essential oils 
and their isolated compounds using specific staining or fluorescent dyes. The most common 
assays performed include neutral red uptake (NRU) (Nathalie et al., 2006; Söderberg et al., 
1996; Stammati et al., 1999), 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide 
(MTT) test (Chung et al., 2007; Sun et al., 2005; Yoo et al., 2005), alamar blue (resazurin) test 
(O’Brien et al., 2000), trypan blue exclusion test (Horvathova et al., 2006; Slameňová et al., 
2007), propidium iodide test (Dušan et al., 2006), and more recently, unscheduled DNA 
synthesis (to detect the presence and removal of adducts of DNA) (Burkey et al., 2000). MTT 
assay and other tetrazolium salts (e.g. XTT) are characterized by the reduction into formazan, 
a coloured product that can be detected spectrometrically (Riss et al., 2013). MTT conversion 
into purple formazan, which is insoluble in the culture medium, is thought to be mediated by 
a reduction reaction catalysed by either NADH or other reducing molecules that transfer 
electrons to MTT. Other spectulation explains this conversion by the envolvement of 
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mitochondrial enzymes, thus MTT is sometimes considered as a measurement of 
mitochondrial activity (Riss et al., 2013). Resazurin is a cell permeable redox indicator which 
is metabolized by metabolically-active cells into resorufin, changing from deep-blue and non-
fluorescent dye (resazurin) into a pink and fluorescent product (resorufin). Resazurin is 
thought to demonstrate toxicity to cells after long periods of incubation, thus the incubation 
time should be enough to provide sensitivity without showing toxicity (Riss et al., 2013).  
 For those assays, cells lines are normally preferred as compared to the use of primary 
cell cultures because they are fully characterized and more easily cultured (Zuzarte, 2012). 
Overall, the majority of toxicity studies have been performed on human fibroblasts or skin 
epithelial cells, although tumour cell lines are also used (Reichling et al., 2009). The cytotoxic 
effect of the essential oils is commonly estimated for a wide range of concentrations (5.0-1950 
µg/mL), depending on the incubation time, which can vary from 1-96h (Reichling et al., 2009).  
Despite their usefulness, it is important to note that in vitro assays may overestimate 
the real in vivo toxicity since cell culture models do not take in account the tissue structure 
nor the biotransformation and transport processes that occur in vivo. Truly, these assays use 
monolayers of cells in which the essential oil/compound is in direct contact with the medium. 
Hence, this is the worst scenario possible and is unlikely to occur in vivo (Reichling et al., 2009). 
Due to this difference between in vitro and in vivo toxicity, the need to find correlation models 
that predict the in vivo toxicity based upon in vitro assays have arisen (Forsby et al., 2009). 
Moreover, the toxicity of essential oils is dependent on the composition, route of 
administration as well as the patient health (Vigan, 2010). The effects of these compounds 
varies from toxic effects (e.g. Hayes e Markovic, 2003; Prashar, Locke e Evans, 2004) to 
adverse reactions such as local irritation on skin and mucous membranes and allergic reactions 
(Schnuch et al., 2004; Veien, 2004). The cytotoxic effect is thought to be due to the induction 
of either apoptosis or necrosis (Bakkali et al., 2008).  
Previously, the cytotoxicity of Daucus carota has been evaluated by a few authors. The 
essential oil of Daucus carota subsp. halophilus was tested against a foetal mouse skin dendritic 
cell line (Tavares et al., 2008). The cytotoxicity of a pentane-based fraction of Daucus carota 
was also evaluated against two different cell lines from human breast adenocarcinoma (MDA-
MB-231 and MCF-7; Shebaby et al., 2014). A methanol:acetone extract from wild carrot was 
assessed against several acute myeloid leukaemia cell lines (HL-60, U937, ML1, ML2, Mono-
Mac-1, Mono-Mac-6, KG-1, MV-4-11, TF1-vRaf, TF1-vSrc and TF1-HaRas) as well as human 
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peripheral blood mononuclear cells (PBMCs) (Tawil et al., 2015). Against non-cancer cell lines, 
such as dendritic cell line (1.25 µL/mL; Tavares et al., 2008) and PBMCs (>100 µg/mL; Tawil et 
al., 2015) the oil demonstrated toxicity at higher concentrations, whereas for cancer cell lines 
the toxicity was demonstrated at lower concentrations (IC50 = 1 – 26.2 µg/mL; (Tawil et al., 
2015). 
In the present study, the essential oil from Daucus carota subsp. carota was selected to 
perform toxicity assays since it demonstrated the most interesting antifungal and antibacterial 
effects and also showed an anti-inflammatory potential The cytotoxicity of the oil was assessed 
on several mammalian cell lines, namely keratinocytes (HaCat), alveolar epithelial cells (A549), 
macrophages (RAW 264.7) and the human hepatocellular carcinoma (HepG2), in order to 
mimetize the different routes of oil administration (oral,  topical or through inhalation)  and 
determine the practical relevance of the referred biological effects.  
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6.2. Material and methods 
  
6.2.1. Essential oil 
The essential oil used in these assays was the same used in the previous assays. 
6.2.2. Reagents and Cell culture  
 Foetal calf serum was purchased from Biochrom KG (Berlin, Germany). DMEM 
(Dulbecco’s modified Eagle’s medium) and trypsin were from Gibco (Invitrogen, Paisley, UK) 
(XX, YY, ZZ). . All the remaining reagents and chemicals were purchased from Sigma-Aldrich 
Co. (St. Louis, USA).  
 The Human keratinocyte cell line, HaCaT (Figure 19a), obtained from DFKZ 
(Heidelberg, Germany) and the human alveolar epithelial cell line, A549 (Figure 19d), obtained 
from ATCC (number CCL-185) were cultured in DMEM medium supplemented with 10 % 
(v/v) inactivated foetal bovine serum, 3.5 g/L glucose, 3.02 g/L sodium bicarbonate, 100 µg/mL 
streptomycin and 100 U/mL penicillin at 37 ºC in a humidified atmosphere of 95% air and 5% 
CO2.  
The Human hepatocellular carcinoma cell line, HepG2 (Figure 19b), obtained from 
ATCC (number HV-8065) was cultured in DMEM Low-Glucose medium supplemented with 
10 % (v/v) inactivated foetal bovine serum, 1.5 g/L sodium bicarbonate, 100 µg/mL 
streptomycin and 100 U/mL penicillin at 37 ºC in a humidified atmosphere of 95% air and 5% 
CO2. 
   
 Mouse leukaemic monocyte macrophage cell line, RAW 264.7 (Figure 19c), purchased 
from ATCC (number TIB-71) was cultured in DMEM supplemented with 10% (v/v) non-
inactivated foetal bovine serum, 3.5 g/L glucose, 3.02 g/L sodium bicarbonate, 100 µg/mL 
streptomycin and 100 U/mL penicillin at 37 ºC in a humidified atmosphere of 95% air and 5% 
CO2. 
 All cell lines were microscopically monitored in order to detect any morphological 
change during the experiments. 
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Figure 20 - Morphological appearance of the cell lines used in the cytotoxicity assay of Daucus carota subsp. 
carota essential oil: a - HaCat (DKFC). b - HepG2 (ATCC number HV-8065). c - RAW 264.7 (ATCC number 
TIB-71). d - A549 (ATCC number CCL-185). Bars = 100 µm 
 
6.2.3. Cytotoxicity assay 
 
RAW 264.7/HepG2/HaCaT/A549 were cultured on DMEM with the formulation 
described above for 48h at 37ºC in humidified atmosphere of 95% air and 5% CO2. When 
confluence reached 80-90% a cell suspension of 0.5x106 cells/mL was prepared for RAW264.7 
and HepG2 while a cell suspension of 0.2x106 cells/mL was prepared for HaCaT and A549,. 
To a 48-well plate, 600µL of the cell suspension was added and the cells were left to stabilize 
for ±12h in the same conditions as above. The depleted medium was carefully removed and 
588µL of fresh medium and following 12µL of essential oil (1.25 – 0.08 µL/mL) was added. The 
plates were then incubated for 24h. At the end, 60 µL of resazurin (C = 0.125 mg/mL) was 
added and the plates were incubated for 30 min for RAW 264.7, 60 min for HepG2. 120 min 
for HaCaT and 60 min for A549 in the same conditions. Cell viability was determined by 
reading the absorbance at 570 nm with a reference filter at 620 nm against a negative control 
(cells without EO) in an ELISA microplate reader (SLT, Austria). A cell-free control was 
performed so that unspecific effects of the oil on resazurin were excluded. All determinations 
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were made in duplicate. Results are shown as mean ± S.E.M of at least three independent 
assay. In this cytotocity assay the metabolic active cells reduce resazurin (blue dye) into 
resorufin (pink colored), therefore their number correlates with the magnitude of dye 
reduction and the viability is evaluated based on a comparison with untreated cells. 
6.2.4. Statistical analysis 
 The statistical analysis comparing the control group with the different treatment groups 
was performed using an ordinary one-way ANOVA with Dunnett’s multiple comparison test 
with significance levels *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. These tests were 
conducted in GraphPad Prism version 6 (GraphPad Software, San Diego, CA, USA). 
 
6.3. Results and discussion 
 
The essential oil Daucus carota subsp. carota had no toxic effect on RAW 264.7 
macrophages (Figure 20a) at concentrations ranging from 0.64 to 0.08 µLmL (92.8-154.6%). In 
fact, it even appears that the concentrations 0.32, 0.16 and 0.08 µg/mL promote either 
metabolic activity or cell growth. The A549 alveolar epithelial cells showed a susceptibility to 
the essential oil similar to that of RAW 264.7. No toxic effect was observed at concentrations 
up to 1.25 µL/mL and for 0.16-0.08 µL/mL, the oil showed a stimulatory effect on cell viability 
(Figure 20b). For HepG2 the concentrations 0.32 and 0.16 µL/mL had no effect on cell viability 
and at lower concentrations (0.08 µL/mL) the oil showed a stimulatory effect on cell viability 
(122.6%) (Figure 20c). Among all types of cells, keratinocytes were the most susceptible to 
Daucus carota subsp. carota essential oil, as only at 0.16 and 0.08 µL/mL no toxicity was 
observed (94.4% and 104.2%, respectively, Figure 20d). 
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Figure 21- Effect of Daucus carota subsp. carota essential on the cell viability of a) RAW 264.7 
macrophages, b) A549 alveolar cells, c) HepG2 hepatocytes and d) HaCaT keratinocytes. Cells where treated 
with essential oil (1.25 – 0.08 µL/mL) for 24h before addition of resazurin (0.125 mg/mL) was added. Results are expressed 
as percentage of resazurin metabolization by control cells. Each bar represents mean S.E.M of at least different experiments, 
performed in duplicate. Statistically difference compared to control cells (*p<0.05, **p<0.01, ***p<0.001, using a one-way 
ANOVA followed by a Dunnett’s multiple comparison test) 
 
The stimulatory effect of essential oils on cell viability was previously assessed by 
Gonçalves and colleagues (Gonçalves et al., 2012) however a reason for this effect was not 
explained. Studies regarding the proliferative effect of D. carota subsp. carota essential oil 
should be conducted in order to elucidate the mechanisms behind such effect. 
Regarding other subspecies of D. carota essential oil some cytotoxic studies have been 
conducted. In fact, the cytotoxicity of the essential oil from D. carota subsp. halophilus (Tavares 
et al., 2008) has been tested on the foetal mouse skin dendritic cell line. However, since the 
authors have used a different cell line, no comparison is possible. Moreover, the cytotoxic 
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effect of the essential oil of D. carota subsp. gummifer has been tested against RAW 264.7, 
HepG2 and HaCaT cell lines. This oil was toxic at 1.25 µL/mL for RAW 264.7 (23%) and 
HaCaT (44.2%) whereas for HepG2 the oil had no significant effect on the cell viability. This 
difference might be explained by the different chemical composition between both essential 
oils (trans-β-ocimene (31.3%), sabinene (29.0%) and cis-β-ocimene (12.3%) of subsp. gummifer 
versus geranyl acetate (29%), α-pinene (27%), 11αH-himachal-4-en-1-β-ol (9.2%) and limonene 
(9%) of subsp. carota). 
As far as we know no studies regarding the toxicity of D. carota subsp. carota have been 
conducted, thus the work presented here is the first of its kind. Regarding the cytotoxic effect 
of the major compounds of the studied essential oil (geranyl acetate, α-pinene and limonene) 
some studies have been conducted. Geranyl acetate was described as having a toxic effect on 
RAW 264.7 macrophages at 1.25 µL/mL (Gonçalves et al., 2012), however other investigators 
have demonstrated that this compound had no effect on RAW 264.7 macrophages at 25 – 500 
mg/mL (Lee et al., 2009). At 100 µg/mL, α-pinene demonstrated a weak activity against 
hepatocyte (HepG2) cell line and no activity against alveolar epithelial cell line (A549) (Dar et 
al., 2011). Limonene only demonstrated cytotoxic activity in RAW 264.7 macrophages at 
concentrations as high as 500 mg/mL (Lee et al., 2009). By analysing these values, it would be 
expected a lower cytotoxic effect of the studied essential oil. However the cytotoxic effect of 
the essential oil was stronger than the isolated major compounds. This might be explained by 
the presence of minor compounds with synergisticeffects that overall lead to a decrease in cell 
viability. 
 In summary, the results shown in the present study suggest that Daucus carota subsp. 
carota essential oil is a promising bioproduct that can be further explored as an antifungal and 
anti-inflammatory drug. This is possible because at biological active concentrations the 
essential oil had no effector very low detrimental effects on cell viability. 
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6. Conclusion and Future perspectives  
  
  The work conducted in this thesis was performed using wild carrot (Daucus 
carota subsp. carota) growing spontaneously in Serra da Lousã, Portugal. The assessment of the 
biological activities: antioxidant, antifungal, antibacterial and anti-inflammatory as well as the 
toxicological profile, allowed a better understanding of the reasons why wild carrots have 
been widely used in folk medicine. In addition, it allowed a better valorisation of this species 
opening pathways to the possible economical exploitation of these plants, especially in the 
health and food sectors. The main conclusions of the present study as well as further research 
perspectives are pointed out below: 
a. The antioxidant potential of D. carota subsp. carota essential oil and phenolic-enriched 
extracts [70% (v/v) and 100% (v/v) methanol and aqueous] were assessed by evaluating 
the scavenging capacity of free radicals (ABTS cation radical and ORAC). For polar 
extracts, the total phenolic content was determined using the Folin Ciocalteu assay. 
The essential oil had a weak performance on both antioxidant assays. This shows that 
the compounds in the essential oil are not good electron and H-atom donors. 
Conversely, 70% methanol extract had a higher activity in ABTS as well as in ORAC, 
showing that phenolic compounds have a tendence to be good donors of H-atom in 
addition to electrons. The total phenolic content of 70% methanol extract was 134.2 
µg GAE/mg DW. The antioxidant activity of isolated compounds from the extracts 
seems to be responsible for the activity of the whole extract, nevertheless the extract´s 
activity is different than the isolated compounds due to the presence of minor 
compounds that might have a synergistic or antagonistic effect. Studies using the minor 
components and the conjugation between minor and major compounds should be 
conducted in order to establish the synergetic or anatogonistic effect between them. 
Also, different methods of NO scavenging should be considered. Moreover, the 
evaluation of the NO scavenging capacity of the phenolic-enriched extracts,as well as 
as well as different antioxidant assays, e.g. ferric reduction antioxidant power, DPPH 
radical scavenging, lipid peroxidation inhibition (TBARS, amongst others), should be 
conducted. 
b. The antibacterial activity of the essential oil and phenolic-enriched extracts from D. 
carota subsp. carota have been assessed against several pathogenic bacteria. The 
essential oil had a higher antibacterial activity against the tested bacteria (MIC = 0.32 - 
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0.64 µL/mL) when compared with the 70% methanol extract (MIC = 5 - 10 mg/mL). 
The bacteria E. coli and S. typhimurium were resistant to both the essential oil and the 
phenolic extract at the tested concentrations. In the future, more assays against other 
pathogenic bacteria such as C. jejuni, H. pylori¸ Pseudomonas spp. or Streptococcus spp. 
should be conducted, along with the effect against biofilm-forming bacteria, e.g. 
Streptococcus spp. The antibacterial activity of both the essential oil and the 
hydromethanolic extract can be explained by the activity of isolated compounds and 
the differences seen between their activities is due to the presence of minor 
compounds that positively or negatively affect the major compounds. Nevertheless, 
studies evaluating the minor compounds activity as well as combination assays using 
both minor and major compounds should be conducted.   
c. The antifungal properties of the essential oil and 70% methanol extract have been 
conducted against several yeasts, dermatophytes and Aspergillus strains. The essential 
oil was effective against dermatophytes (MIC = 0.31 – 0.62 µL/mL) and the yeast 
Cryptococcus neoformans (MIC = 0.16 µg/mL). All the tested yeasts from the genus 
Candida, except C. guillermondi (MIC of 0.32 µL/mL), were resilient to the action of the 
essential oil. However the essential oil was able to disrupt the preformed biofilm of C. 
albicans at concentrations lower than the MIC (1.25 µL/mL) thus making it promissing 
for pharmacological application in the treatment of candidiosis. Regarding the effect on 
the tested Aspergillus strains, the essential oil demonstrated fungistastic effect against 
A. fumigatus and A. niger (MIC of 1.25 and 2.5 µL/mL, respectively) however without 
fungicidal effect (MLC higher than 10 µL/mL). The essential oil had no effect on A. flavus 
for the tested concentrations. The 70% methanol extract had a significant effect against 
all tested dermatophytes (MIC on the range of 1.25 and 10 mg/mL) except T. 
verrucosum. Nevertheless, it had no inhibitory effect against all tested yeast and 
Aspergillus strains. Further research regarding the antifungal activity of the essential oil 
and phenolic-enriched extracts should be carried out in order to further elucidate the 
mechanisms of action underlying these inhibitory effects. Other points that could be of 
interest to study is the inhibitory effect against other pathogenic fungi involved in 
human, animal or plant infections in order to outline a broader application of these 
compounds. The antifungal activity of both the essential oil and the hydromethanolic 
extract is explained by the activity of isolated compounds and any difference seen 
between their activities is due to the presence of minor compounds that positively or 
negatively effect the major ones. Nevertheless, studies evaluating the minor 
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compounds as well as combination between minor and major compounds shouldbe 
conducted in order to clarify their contribution to the activity of the extracts. 
d. The anti-inflammatory activity of the essential oil was carried out by evaluating it 
capability to inhibit NO release on LPS-stimulated RAW 264.7 macrophages. The 
essential oil was able to reduce by 19% the NO production in LPS-stimulated 
macrophages at 0.64 µL/mL without showing toxicity to the cells. Nevertheless,  
studies focusing on distinct inflammatory markers (e.g. TNF-α or IL-1β release) should 
also be conducted in order to elucidate the mechanism of action associated to this 
anti-inflammatory potential. Studies using phenolic-enriched extracts should also be 
performed, as phenolic compounds are also described as potential anti-inflammatory 
agents. The isolated major compounds of the essential oil are responsible for its anti-
inflammatory activity however there are differences between their activities due to the 
antagonistic effects of other compounds. 
e. The safety profile of the essential oil was evaluated on macrophages, keratinocytes, 
alveolar epithelial cells and hepatocytes. The essential oil was toxic for all cell lines only 
at higher concentrations (1.25 µL/mL). However at 0.64 – 0.08 µL/mL the toxicity was 
greatly dependent on the cell line being hepatocytes and keratinocytes slightly more 
susceptible. At 0.32 µL/mL the essential oil was able to inhibit the growth of C. 
guillermondi, C. neoformans, E. floccosum and T. rubrum without showing significant 
toxicity to keratinocytes, thus justifying a potential topical application. Also, at 0.64 
µL/mL, the oil showed an anti-inflammatory potential without affecting macrophages 
viability. The cytotoxic effect of the essential oil at higher concentrations may be 
explained by the major compounds found as they are known to be toxic towards the 
studied cells lines. Research using phenolic-enriched extracts should be also performed 
together with individual components in order to evaluate which are responsible for 
the toxicity of both essential oil and extracts. In some cell lines, the essential oil had a 
stimulatory effect on them, further research should be conducted in order to clarify 
the reasons behind this effect. Also, cytotoxic effects on cancer cell lines should be 
evaluated thus elucidating the anti-cancer properties of the essential oil and phenolic-
enriched extracts 
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